rfhg_42413.1

Basic information about the TSS

---

TSS ID: rfhg_42413.1 TSS ID(Version3): hg_41104.1 Species: human Chr: chr3		Start: 11643804 End: 11643825 Strand: -
Source datasets	FANTOM5|DBTSS|PRJNA548673|PRJNA615891
Protocol	CAGE|TSS-seq|ReCappable-seq|SLIC_CAGE
TSS cluster detected*	4

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D3393516,EH38E2178686)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000430365.7:-90 GeneID: 9686 HGNC/MGI_ID: HGNC:28966 UniProt_ID: G5E9M7 Nearer transcript ids and distances:

Gene_name: vestigial like family member 4 Gene_symbol: VGLL4 Gene_synonyms: KIAA0121 Gene_source: HGNC:28966

TATA-Box annotation

---

Distance to TSS:	101
Nearest PromoterID:	NM_001128219
Entrez ID:	9686
Nearest Unigene:	Hs.740389
Nearest Refseq:	NM_014667
Nearest Ensembl:	ENSG00000144560
Gene Name:	vestigial like family member 4
Gene Alias:	VGL-4
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.318182
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@VGLL4 p2@VGLL4 p3@VGLL4 p4@VGLL4 p5@VGLL4 p6@VGLL4 p7@VGLL4 p8@VGLL4 p9@VGLL4 p10@VGLL4
Sample		p1@VGLL4	p2@VGLL4	p3@VGLL4	p4@VGLL4	p5@VGLL4	p6@VGLL4	p7@VGLL4	p8@VGLL4	p9@VGLL4	p10@VGLL4
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	7.79	8.57	2.34	2.53	0.00	0.97	0.97	0.00	0.19	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	7.49	8.50	0.61	4.25	0.20	1.21	0.61	0.00	0.00	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	9.07	10.42	1.35	2.12	0.00	0.58	0.58	0.00	0.19	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	9.77	7.48	1.46	2.08	0.00	1.25	0.83	0.00	0.00	0.62
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	8.77	9.67	1.57	2.02	0.00	1.57	0.45	0.00	0.22	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	7.95	10.85	1.74	2.13	0.00	1.16	0.39	0.00	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	10.68	10.24	3.05	3.05	0.44	1.31	0.44	0.00	0.22	0.44
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	9.20	11.63	2.42	3.39	0.48	0.97	0.24	0.00	0.00	0.73
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	9.40	14.96	1.50	2.78	0.00	0.64	0.43	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	8.69	6.38	2.32	5.22	0.58	1.16	0.58	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	19.81	4.45	2.02	5.26	0.00	2.43	0.40	0.00	0.40	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	15.04	5.69	2.85	3.66	0.41	1.63	0.41	0.00	0.00	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	38.53	3.71	7.09	1.29	0.64	0.32	0.32	4.03	0.32	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	39.24	2.41	7.22	0.90	0.90	0.15	0.30	4.06	0.60	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	31.18	1.98	5.93	0.44	1.10	0.22	0.22	2.63	0.44	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	35.71	2.26	3.52	0.50	1.51	0.25	0.25	3.77	0.75	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	36.47	3.06	5.02	0.87	1.09	0.00	0.22	4.15	0.22	0.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	32.90	3.37	5.06	1.27	1.69	0.00	0.00	6.33	0.84	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	35.19	2.13	4.80	1.60	0.53	0.53	0.00	5.86	0.00	2.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	39.11	2.86	6.62	0.45	1.96	0.15	0.30	5.27	0.15	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	39.96	3.07	7.35	0.94	0.53	0.13	0.27	5.61	0.67	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	44.88	2.76	7.60	1.21	1.73	0.17	0.17	4.83	0.52	2.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	37.74	2.71	4.39	0.90	1.94	0.13	0.00	4.14	0.26	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	28.88	2.18	5.34	0.73	1.21	0.73	0.24	4.37	0.00	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	39.47	1.81	3.87	1.55	1.29	0.00	0.26	6.71	1.03	1.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	32.28	3.17	5.70	1.27	1.90	0.00	0.00	7.28	0.32	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	44.51	4.40	4.95	1.65	3.85	0.00	0.00	6.59	0.55	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	52.57	1.65	7.07	0.00	1.65	0.00	0.47	10.37	0.71	1.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	40.70	2.42	5.17	0.81	1.29	0.16	0.16	6.46	0.81	1.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	45.06	1.99	5.25	0.90	1.81	0.00	0.36	7.60	0.36	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	44.80	2.51	4.40	0.42	0.42	0.21	0.00	6.28	0.63	1.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	45.33	1.56	6.45	0.78	0.78	0.20	0.00	6.06	0.98	1.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	41.99	2.32	6.33	0.84	1.06	0.42	0.00	5.06	0.63	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	63.50	2.47	4.12	0.49	1.81	0.16	0.00	5.61	1.32	3.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	51.80	1.68	4.49	1.31	1.50	0.19	0.19	6.54	1.68	1.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	48.67	2.30	4.98	0.77	0.77	0.19	0.00	5.56	1.34	2.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	46.80	0.82	4.70	1.23	2.45	0.20	0.20	4.70	0.00	1.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	45.13	1.21	3.63	0.00	0.81	0.00	0.00	4.03	1.21	2.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	46.73	1.08	6.75	0.81	0.81	0.27	0.00	3.24	1.08	3.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	38.41	2.64	4.32	0.48	0.24	0.24	0.24	4.80	0.00	1.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	35.76	1.41	3.76	0.94	1.41	0.00	0.00	3.29	0.47	2.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	44.36	1.46	2.93	0.73	1.46	0.29	0.00	2.49	0.44	2.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	45.13	0.84	5.91	0.42	1.27	0.21	0.00	3.80	1.05	2.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	40.04	0.70	5.24	0.87	1.40	0.00	0.00	3.15	0.35	3.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	40.96	1.61	6.63	1.00	1.61	0.20	0.00	5.22	0.40	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	45.83	2.33	5.12	1.86	1.16	0.23	0.00	2.33	0.93	1.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	47.98	0.96	4.80	1.44	0.48	0.24	0.24	4.32	0.48	2.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	37.85	1.19	4.47	2.38	2.09	0.30	0.30	1.79	0.60	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	50.99	2.63	5.27	2.63	1.91	0.72	0.00	1.91	1.20	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	58.84	2.22	9.30	1.42	2.43	0.20	0.00	1.82	0.20	2.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	83.01	2.87	5.94	1.23	2.66	0.41	0.00	3.07	0.20	3.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	87.17	3.11	6.23	0.67	0.89	0.00	0.22	2.22	0.22	4.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	111.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	78.78	2.48	7.45	2.13	1.06	0.35	0.00	1.77	0.00	1.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	87.49	3.65	6.30	0.33	1.99	0.00	0.66	3.98	0.33	2.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	162.75	0.84	3.36	0.00	3.36	0.00	0.84	1.68	5.03	2.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	104.71	3.21	5.51	0.46	2.76	0.00	0.00	0.92	0.00	2.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	102.42	0.97	5.83	1.30	0.97	0.32	0.00	0.65	0.32	2.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	85.75	0.64	5.78	0.64	1.61	0.00	0.32	0.32	0.32	2.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	139.88	0.94	2.83	0.00	3.77	0.31	0.00	1.57	0.31	1.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	87.43	0.00	7.76	0.71	2.12	0.00	0.00	1.41	0.00	2.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	102.62	1.12	1.68	0.56	1.12	0.00	0.00	1.68	0.00	2.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	174.36	0.80	3.98	1.59	4.78	0.00	0.00	3.18	2.39	3.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	129.79	0.34	2.72	0.68	2.04	0.34	0.00	1.02	0.00	3.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	109.82	1.95	5.85	3.25	1.62	0.00	0.00	1.30	0.32	3.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	77.39	0.71	3.90	1.77	1.77	0.00	0.00	0.71	1.06	3.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	64.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	16.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	134.26	0.00	0.00	0.00	0.00	0.00	7.90	0.00	7.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	50.70	0.98	4.39	0.98	0.00	0.00	0.00	0.00	0.00	1.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	45.62	0.99	6.45	2.48	0.99	0.00	0.00	0.50	0.50	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	38.47	2.35	1.88	1.41	2.35	0.47	0.47	0.00	0.00	2.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	36.43	1.32	4.64	0.66	1.32	0.00	0.00	0.00	0.33	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	39.91	1.24	4.33	1.86	0.62	0.00	0.31	0.00	0.00	1.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	26.29	1.53	4.59	1.53	0.31	0.00	0.00	0.00	0.00	0.92
Adipocyte - breast, donor1	11376-118A8	33.10	8.39	6.97	2.38	4.43	1.58	0.63	2.06	0.95	0.79
Adipocyte - breast, donor2	11327-117E4	28.24	4.33	7.38	1.93	3.21	0.96	0.00	2.41	1.28	0.64
Adipocyte - omental, donor1	11473-119C6	42.11	12.60	8.02	1.91	4.58	2.80	1.15	1.40	0.51	0.64
Adipocyte - omental, donor2	11474-119C7	12.71	0.75	5.23	0.00	0.75	0.75	0.00	1.49	0.00	1.49
Adipocyte - omental, donor3	11475-119C8	26.46	4.69	4.35	0.33	0.00	0.67	0.00	1.00	1.67	0.00
Adipocyte - perirenal, donor1	11476-119C9	22.33	7.02	5.10	1.91	2.55	0.64	0.64	1.28	0.64	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	14.29	2.20	2.20	0.00	0.00	0.00	0.00	0.00	0.00	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	15.81	4.52	1.81	0.00	0.00	0.90	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	11.12	1.39	4.52	0.35	0.00	0.35	0.35	0.17	0.52	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	30.90	2.15	2.15	1.17	1.56	0.39	0.00	0.39	0.78	1.17
Adipocyte differentiation, day04, donor2	13022-139D7	38.09	0.26	2.83	0.51	0.77	0.51	0.00	0.00	0.51	0.77
Adipocyte differentiation, day04, donor3	13025-139E1	12.82	5.02	2.23	0.84	1.67	0.00	0.28	0.28	0.00	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	19.99	2.94	4.11	2.94	1.18	0.00	0.00	0.59	0.00	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	28.39	2.57	1.85	0.97	0.48	0.40	0.40	0.08	0.40	0.24
Adipocyte differentiation, day08, donor2	13023-139D8	25.17	1.29	2.58	0.97	0.65	0.00	0.00	0.00	0.32	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	21.86	1.60	2.67	0.53	1.07	1.07	0.00	0.00	0.53	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	20.59	2.78	1.67	1.11	2.78	0.00	0.56	1.67	1.11	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	18.30	2.50	3.33	1.25	1.66	0.00	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	25.37	1.00	2.51	0.75	1.00	0.25	0.00	0.00	0.00	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	20.62	1.96	1.96	0.65	0.98	0.65	0.65	0.00	0.00	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	16.44	2.13	0.91	0.61	1.22	0.00	0.30	0.30	0.00	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	14.14	5.52	3.31	1.10	0.00	0.22	0.66	0.00	0.66	0.88
Alveolar Epithelial Cells, donor2	11590-120G6	8.61	5.38	3.23	4.66	0.00	1.08	0.00	0.00	0.36	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	3.59	1.20	0.00	1.20	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	11.15	5.94	2.70	2.88	0.18	0.54	0.36	0.00	0.54	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	8.37	6.69	6.69	3.35	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	9.04	4.31	6.57	3.08	0.00	0.21	0.21	0.00	0.21	0.00
Anulus Pulposus Cell, donor1	11248-116E6	42.45	1.03	2.63	0.23	1.95	0.11	0.00	2.98	1.26	2.40
Anulus Pulposus Cell, donor2	11463-119B5	35.02	1.22	3.43	0.00	0.24	0.24	0.00	3.18	1.22	0.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	16.17	0.90	1.80	0.00	0.90	0.00	0.00	0.00	0.90	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	21.27	2.17	3.47	0.43	1.74	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	38.52	0.00	4.28	2.14	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	20.33	1.20	2.69	0.90	1.49	0.00	0.00	0.90	0.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	18.97	0.00	3.79	0.00	0.00	0.00	0.00	0.00	1.26	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	24.42	0.66	0.66	1.32	0.00	0.00	0.00	0.00	0.66	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	20.14	0.65	1.62	0.32	0.32	0.00	0.00	0.00	0.00	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	16.99	0.97	0.97	0.49	0.97	0.00	0.00	0.00	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	19.00	0.59	4.75	0.59	0.59	0.00	0.00	0.00	1.19	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	19.21	0.00	3.77	1.13	0.75	0.00	0.00	0.75	0.38	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	15.24	0.00	0.00	0.00	0.73	0.00	0.00	0.00	0.00	1.45
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	16.30	0.00	1.25	1.25	1.25	0.00	0.00	1.25	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	22.40	1.15	1.98	0.49	1.48	0.00	0.00	0.33	0.33	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	17.74	0.00	2.73	0.00	1.36	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	21.56	0.60	0.90	0.30	0.90	0.15	0.00	0.45	0.60	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	15.00	1.07	2.68	0.54	0.54	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	23.43	0.76	3.40	0.19	1.70	0.19	0.00	0.19	0.94	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	25.66	0.53	2.41	0.27	0.80	0.00	0.00	0.00	0.80	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	15.61	0.98	0.98	0.00	0.00	0.00	0.00	0.98	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	13.77	0.33	2.65	1.00	0.83	0.00	0.00	0.00	0.66	0.50
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	28.82	1.20	3.60	0.00	2.40	0.00	0.00	2.40	1.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	17.70	0.00	7.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	20.76	1.54	2.40	0.86	0.51	0.00	0.17	0.17	0.17	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	37.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00	4.19	4.19
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	19.90	0.49	3.88	0.00	0.49	0.00	0.00	0.97	1.46	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	24.28	1.14	2.66	0.38	0.76	0.00	0.00	0.38	0.38	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	24.23	1.21	2.42	0.00	1.21	0.00	0.00	2.42	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	21.09	0.00	2.85	0.57	0.00	0.00	0.00	0.57	1.14	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	16.89	1.07	3.85	0.64	0.43	0.00	0.00	0.86	0.86	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	18.58	0.52	2.84	0.52	0.00	0.00	0.00	0.52	0.26	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	20.65	0.47	1.88	0.47	0.47	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	20.58	0.64	3.54	0.64	0.00	0.00	0.00	0.32	0.96	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	25.68	0.00	0.71	0.71	0.71	0.00	0.00	0.00	0.00	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	23.40	1.17	1.75	1.17	0.58	0.00	0.00	0.58	1.75	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	23.18	0.30	3.01	0.60	0.60	0.00	0.00	0.60	1.20	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	34.45	1.19	2.38	0.00	0.00	0.00	0.00	0.00	2.38	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	21.87	0.00	2.54	0.51	0.00	0.00	0.00	0.51	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	25.72	0.51	1.78	0.76	0.25	0.00	0.51	0.25	0.25	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	21.60	2.54	0.00	0.00	1.91	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	21.15	0.00	1.73	0.86	0.86	0.00	0.00	0.43	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	15.24	0.85	4.45	0.85	0.85	0.00	0.00	0.42	0.85	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	18.85	0.00	2.32	0.58	0.87	0.29	0.00	0.29	0.87	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	16.06	0.00	0.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	17.46	0.85	2.54	0.68	0.51	0.00	0.00	1.36	0.85	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	30.11	0.00	4.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	23.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	22.73	0.43	3.86	0.43	1.29	0.00	0.00	1.07	1.29	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	28.28	0.60	1.80	0.00	2.41	0.00	0.00	1.20	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	20.41	0.00	0.73	0.00	1.46	0.00	0.00	0.73	4.37	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	22.30	0.69	1.61	0.92	2.30	0.00	0.00	0.69	1.15	0.92
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	17.85	0.00	0.00	0.00	2.55	0.00	0.00	0.00	0.00	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	24.66	0.25	2.54	0.25	1.78	0.00	0.25	0.00	0.76	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	22.71	0.41	3.92	0.21	1.03	0.21	0.00	0.41	2.48	1.24
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	25.70	0.92	2.14	0.31	1.53	0.31	0.00	0.31	1.22	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	20.55	1.43	1.43	0.00	0.96	0.00	0.00	0.00	0.48	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	20.62	1.11	1.77	0.00	1.11	0.22	0.00	0.89	1.11	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	25.94	0.00	1.53	1.53	0.00	0.00	0.00	0.00	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	16.62	0.00	1.66	0.00	0.00	0.00	0.00	0.00	1.66	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	21.45	1.32	2.12	0.79	1.32	0.00	0.00	0.26	0.53	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	27.62	1.09	1.82	0.00	1.45	0.00	0.00	0.36	0.36	0.36
Astrocyte - cerebellum, donor1	11500-119F6	52.44	1.60	4.42	1.23	2.46	0.00	0.12	0.49	0.98	1.35
Astrocyte - cerebellum, donor2	11580-120F5	41.59	1.54	2.57	0.51	1.20	0.00	0.00	0.51	1.37	1.03
Astrocyte - cerebellum, donor3	11661-122F5	42.16	3.78	3.99	0.63	2.10	0.21	0.21	0.21	1.05	1.47
Astrocyte - cerebral cortex, donor1	11235-116D2	36.25	3.49	10.46	1.05	2.44	1.39	0.70	1.05	0.35	2.44
Astrocyte - cerebral cortex, donor2	11316-117D2	34.13	6.47	6.96	1.46	2.75	0.81	0.65	1.29	0.97	1.13
Astrocyte - cerebral cortex, donor3	11392-118C6	35.80	7.31	8.80	3.28	1.34	0.60	0.75	0.75	0.45	1.34
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	67.09	0.34	1.38	0.57	0.46	0.00	0.11	0.00	1.03	0.69
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	61.01	0.25	0.88	0.13	0.50	0.00	0.13	0.00	0.38	1.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	62.02	0.23	1.14	0.68	1.02	0.00	0.00	0.00	0.80	0.46
Basophils, donor1	12241-129G9	13.34	0.78	0.26	0.00	0.78	0.52	0.00	0.00	0.00	0.52
Basophils, donor2	12242-129H1	24.89	2.53	1.80	0.00	1.08	0.72	0.72	0.00	0.00	0.00
Basophils, donor3	12243-129H2	13.67	1.03	0.73	0.29	0.59	0.44	0.00	0.00	0.29	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	2.16	12.94	3.23	2.37	0.00	3.45	2.59	0.00	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	2.74	4.11	4.57	4.57	0.00	0.46	0.46	0.00	0.46	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	0.00	43.04	0.00	0.00	0.00	7.17	0.00	0.00	7.17	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	2.51	8.79	3.77	1.26	0.00	2.51	0.63	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	6.03	6.03	2.29	3.12	0.00	1.25	0.00	0.00	0.21	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	1.61	8.52	1.38	0.92	0.00	0.92	1.38	0.00	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	1.98	8.10	2.52	2.34	0.00	1.44	1.80	0.00	0.00	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	19.07	14.12	4.53	1.75	0.21	3.40	2.78	0.00	0.31	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	31.21	15.14	2.79	2.10	0.00	2.56	3.49	0.00	1.16	0.47
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	48.61	3.84	4.80	1.60	0.64	0.00	0.00	0.00	0.00	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	51.71	10.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00	10.34
CD14+ Monocytes, donor1	11224-116B9	10.71	0.00	1.69	0.00	0.56	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	11.32	1.11	0.00	0.19	0.37	0.19	0.00	0.00	0.37	0.00
CD14+ Monocytes, donor3	11381-118B4	10.54	1.32	0.66	0.00	0.44	0.22	0.22	0.00	0.66	0.66
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	27.17	0.57	1.13	0.00	2.83	0.00	0.00	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	25.78	0.76	0.00	0.76	0.76	0.00	0.00	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	29.26	1.31	0.99	0.33	2.63	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	13.01	0.29	0.29	0.14	0.43	0.00	0.00	0.00	0.00	0.14
CD14+ monocytes - mock treated, donor2	11873-125C1	9.66	0.30	0.30	0.00	0.30	0.00	0.00	0.30	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	15.16	0.24	0.00	0.00	0.71	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	5.69	0.00	0.17	0.00	0.17	0.00	0.00	0.00	0.17	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	7.45	0.28	0.28	0.00	0.83	0.28	0.00	0.28	0.28	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	6.94	0.00	0.25	0.00	0.50	0.00	0.00	0.00	0.00	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	8.42	0.20	0.00	0.00	3.13	0.00	0.00	0.00	0.59	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	9.44	0.18	0.36	0.00	2.49	0.00	0.00	0.00	0.18	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	7.62	0.00	0.00	0.00	2.39	0.00	0.00	0.00	0.22	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	11.71	0.23	0.00	0.00	1.17	0.00	0.00	0.00	0.23	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	13.73	0.53	0.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	8.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	6.69	0.00	0.30	0.00	0.59	0.15	0.00	0.15	0.00	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	6.19	0.20	0.00	0.00	0.40	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	4.79	0.00	0.00	0.00	0.42	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	6.63	0.46	0.00	0.00	0.69	0.00	0.00	0.00	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	5.88	0.68	0.00	0.00	0.23	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	6.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	12.91	0.00	0.00	0.00	5.38	0.00	0.00	0.00	0.81	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	13.43	0.52	0.17	0.00	6.63	0.00	0.00	0.00	0.87	0.35
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	13.89	0.42	0.00	0.00	4.63	0.00	0.00	0.00	1.68	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	3.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.37	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	2.11	0.00	0.00	0.00	0.35	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	0.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	9.59	0.17	0.00	0.00	1.92	0.00	0.00	0.00	0.17	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	11.89	0.00	0.00	0.00	1.86	0.00	0.00	0.00	0.74	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	9.48	0.00	0.22	0.00	1.08	0.00	0.00	0.00	0.43	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	5.32	2.87	0.82	0.82	0.00	0.00	0.00	0.00	0.41	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	4.87	0.23	0.00	0.00	0.23	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	4.64	0.00	0.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	13.08	0.44	0.00	0.00	0.22	0.00	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	12.24	0.92	0.00	0.00	0.23	0.00	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	12.35	0.43	0.22	0.00	0.00	0.00	0.00	0.00	0.22	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	21.49	0.47	0.16	0.16	1.40	0.00	0.00	0.00	0.16	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	20.61	0.52	0.52	0.00	0.70	0.00	0.00	0.00	0.35	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	29.43	0.22	0.22	0.00	0.67	0.00	0.00	0.00	0.22	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	5.61	0.77	0.00	0.00	0.00	0.00	0.00	0.00	0.26	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	8.78	0.44	0.66	0.22	0.66	0.00	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	8.63	0.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	22.36	0.00	4.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	22.37	2.71	2.71	1.36	0.00	0.00	1.36	0.00	0.68	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	17.61	3.11	1.04	1.04	1.04	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	29.85	3.20	2.13	1.60	0.53	0.00	0.00	0.00	0.53	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	26.27	2.14	3.22	1.61	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	21.06	3.51	1.40	0.00	0.00	0.00	1.40	0.00	0.70	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	19.61	2.35	2.35	0.78	0.00	0.00	0.00	0.00	0.00	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	21.09	2.64	1.32	0.00	1.32	1.32	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	15.62	4.93	2.47	1.64	0.82	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	6.53	1.45	2.90	0.00	0.00	0.73	1.45	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	14.64	3.53	2.02	1.51	0.50	0.00	2.02	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	22.22	0.81	0.81	0.00	0.00	0.00	0.00	0.00	0.40	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	14.38	0.80	0.40	0.40	0.00	0.00	0.00	0.00	0.40	0.00
CD34+ Progenitors, donor1	11545-120B6	37.15	3.01	3.01	0.00	1.00	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	17.98	1.12	0.56	0.00	0.00	1.12	0.00	0.00	0.56	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	38.70	2.63	3.38	0.00	0.38	0.38	0.38	0.00	0.38	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	50.51	2.48	3.16	1.13	0.90	0.23	0.90	0.00	0.00	0.00
CD4+ T Cells, donor1	11225-116C1	10.35	3.57	2.50	0.71	0.00	1.79	2.50	0.00	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	13.47	7.96	3.67	1.22	0.00	0.00	0.00	0.00	0.61	0.00
CD4+ T Cells, donor3	11382-118B5	11.28	3.05	4.88	2.74	0.00	0.91	0.61	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	32.42	1.28	0.77	0.51	0.26	0.00	0.51	0.00	0.51	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	24.26	2.47	0.90	0.22	0.22	0.00	0.45	0.00	0.45	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	24.72	2.01	1.72	1.15	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	12.33	0.95	1.90	1.42	0.47	0.47	0.47	0.00	0.00	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	13.34	3.51	2.81	3.51	0.00	0.70	1.40	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	29.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	36.85	2.75	1.30	0.29	0.00	0.29	0.14	0.00	0.58	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	32.20	6.10	3.39	1.69	0.17	0.34	0.85	0.00	0.85	0.34
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	30.79	4.51	2.42	0.97	0.16	0.48	0.64	0.00	0.97	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	8.07	3.14	1.79	0.90	0.00	0.00	0.00	0.00	0.45	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	10.83	1.75	2.45	1.05	0.35	0.00	0.70	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	18.04	2.64	1.76	0.88	0.00	0.00	1.32	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	56.50	0.84	0.00	0.00	0.84	0.00	0.00	0.00	2.11	1.26
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	48.41	0.42	0.62	0.83	0.83	0.21	0.00	0.00	0.83	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	52.79	0.67	1.00	0.00	0.33	0.00	0.67	0.00	0.67	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	38.89	1.09	1.09	0.54	0.27	0.00	0.54	0.00	0.82	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	39.12	2.68	2.14	1.61	1.07	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	44.83	0.00	7.17	3.59	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	50.07	2.60	0.93	1.30	0.37	0.19	0.93	0.00	1.11	0.37
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	32.93	3.68	1.30	1.30	0.22	0.43	0.00	0.00	0.43	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	39.93	3.99	2.10	1.47	0.00	0.21	0.00	0.00	0.84	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	17.19	0.51	1.01	0.51	0.00	0.00	1.01	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	16.46	3.03	2.60	1.73	0.00	0.87	1.30	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	29.20	5.67	3.05	0.44	0.44	0.44	0.44	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	41.57	0.49	3.96	0.49	0.00	0.00	1.48	0.00	1.98	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	50.78	0.92	5.54	1.85	0.00	0.00	0.92	0.00	0.00	1.85
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	33.50	1.40	2.79	1.40	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	34.62	3.88	2.22	1.94	0.00	0.83	0.28	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	46.62	2.45	4.66	2.21	0.49	0.00	0.49	0.00	0.49	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	69.30	7.70	0.00	1.54	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	42.26	1.79	3.58	1.43	0.36	0.00	0.36	0.00	0.72	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	27.70	2.77	11.08	1.38	0.00	1.38	0.00	0.00	0.00	1.38
CD8+ T Cells, donor1	11226-116C2	21.61	3.27	5.57	2.62	0.65	1.96	1.64	0.00	0.65	0.00
CD8+ T Cells, donor2	11307-117C2	13.14	4.13	6.01	1.13	0.00	1.13	0.75	0.00	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	15.91	5.05	5.30	0.25	0.00	2.78	2.52	0.00	0.25	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	4.59	1.61	0.46	0.23	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	5.03	1.68	0.48	0.24	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	6.84	0.27	0.00	0.27	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	6.60	0.30	0.30	0.00	0.30	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	6.24	0.48	0.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	6.37	0.45	0.23	0.23	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	6.74	0.87	1.09	0.22	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	5.79	0.00	0.53	0.00	0.00	0.26	0.00	0.00	0.26	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	8.44	0.47	0.47	0.23	0.00	0.00	0.00	0.00	0.23	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	7.85	0.00	0.30	0.60	0.30	0.30	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	7.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	7.99	0.53	0.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	6.13	0.88	0.44	0.00	0.00	0.44	0.00	0.00	0.44	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	8.20	1.37	0.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	6.71	1.49	1.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	8.64	0.72	0.00	0.36	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	9.21	0.29	0.00	0.00	0.29	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	5.66	0.24	0.94	0.24	0.00	0.00	0.00	0.00	0.00	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	6.34	0.00	0.63	0.63	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	8.92	0.31	0.00	0.31	0.00	0.00	0.00	0.00	0.31	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	7.37	1.28	0.64	0.64	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	8.80	0.76	0.00	0.38	0.38	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	5.91	0.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	8.32	0.76	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	4.82	0.00	0.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	3.50	0.00	1.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	7.01	0.00	2.00	0.00	1.00	0.00	1.00	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	42.04	0.00	3.66	0.00	3.66	0.00	0.00	0.00	1.83	0.00
Cardiac Myocyte, donor2	11605-120I3	20.26	0.00	3.95	0.49	0.49	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	10.84	4.31	1.79	0.42	0.74	0.21	0.00	0.00	0.32	0.21
Chondrocyte - de diff, donor1	11261-116G1	21.15	4.16	2.77	0.00	1.73	0.35	0.00	0.35	0.35	0.00
Chondrocyte - de diff, donor2	11338-117F6	23.10	4.98	1.78	1.07	0.36	0.71	0.71	0.71	0.36	0.00
Chondrocyte - de diff, donor3	11410-118E6	30.04	3.30	4.32	0.46	2.16	1.71	0.23	1.93	0.57	0.80
Chondrocyte - re diff, donor2	11339-117F7	128.02	2.69	4.48	0.00	4.48	0.00	0.00	0.90	1.79	0.00
Chondrocyte - re diff, donor3	11411-118E7	71.58	3.64	4.45	1.62	5.26	0.00	0.40	2.83	1.62	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	50.26	1.72	4.93	0.92	3.10	0.00	0.00	0.80	0.80	1.72
Ciliary Epithelial Cells, donor2	11323-117D9	48.95	0.86	3.42	0.43	1.50	0.00	0.00	1.28	1.71	2.14
Ciliary Epithelial Cells, donor3	11399-118D4	49.03	0.88	3.54	0.80	1.50	0.00	0.00	0.53	0.44	1.77
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	37.32	12.01	10.82	1.38	2.48	0.55	0.46	0.55	0.46	0.92
Corneal Epithelial Cells, donor1	11526-119I5	2.85	16.91	3.29	2.85	0.00	2.20	1.98	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	5.69	27.30	1.14	2.28	0.00	6.83	2.28	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	3.32	9.20	4.60	4.60	0.00	3.32	2.05	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	23.94	1.32	1.32	1.16	0.17	0.00	0.00	0.00	0.50	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	20.50	1.26	1.58	0.00	0.95	0.00	0.00	0.00	0.63	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	17.25	0.00	3.45	0.00	0.00	0.00	0.00	0.00	3.45	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	19.55	1.08	2.48	0.86	0.76	0.00	0.00	0.00	0.22	0.22
Dendritic Cells - plasmacytoid, donor1	11228-116C4	32.80	0.00	0.68	0.00	1.71	0.00	0.00	0.00	0.00	1.02
Dendritic Cells - plasmacytoid, donor2	11309-117C4	22.85	0.00	1.96	0.00	1.31	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	30.49	0.48	0.00	0.00	0.48	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	20.85	1.50	1.83	1.33	1.83	0.17	0.33	0.83	0.50	0.83
Endothelial Cells - Aortic, donor1	11263-116G3	29.34	2.35	0.59	0.59	0.00	0.00	0.00	1.17	1.17	1.17
Endothelial Cells - Aortic, donor2	11340-117F8	33.37	4.81	3.68	1.98	0.28	0.00	0.57	0.28	0.57	1.70
Endothelial Cells - Aortic, donor3	11412-118E8	38.93	4.33	5.11	0.39	0.00	0.79	0.00	3.93	0.00	0.39
Endothelial Cells - Artery, donor1	11264-116G4	27.63	2.04	3.20	0.87	1.75	0.00	0.00	1.16	0.00	0.87
Endothelial Cells - Artery, donor2	11341-117F9	31.29	1.65	2.35	0.47	2.82	0.24	0.00	1.41	0.24	0.94
Endothelial Cells - Artery, donor3	11413-118E9	32.08	4.03	2.98	0.70	0.70	0.18	0.00	1.58	0.70	1.23
Endothelial Cells - Lymphatic, donor1	11236-116D3	37.46	1.99	3.10	0.89	2.22	0.00	0.00	0.89	0.66	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	30.43	3.96	4.87	0.91	1.52	0.91	0.00	1.52	0.30	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	36.08	4.23	3.38	1.13	2.54	0.28	0.28	0.00	0.28	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	19.02	2.67	4.75	1.49	0.89	0.89	0.30	1.49	0.89	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	21.35	3.12	0.52	1.04	0.00	0.00	0.00	0.52	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	14.18	5.81	4.54	1.56	0.85	1.42	0.28	0.71	0.14	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	18.41	2.40	1.60	0.80	0.80	0.00	0.00	2.00	0.00	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	39.31	2.10	1.05	0.00	2.10	0.00	0.00	1.05	0.00	2.10
Endothelial Cells - Umbilical vein, donor1	11243-116E1	36.65	6.96	2.86	1.86	2.73	0.12	0.12	1.12	0.62	0.62
Endothelial Cells - Umbilical vein, donor2	11324-117E1	23.03	1.96	5.65	2.82	1.74	0.22	0.00	1.09	0.43	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	21.74	5.74	4.15	1.34	0.85	0.00	0.24	0.98	0.12	0.61
Endothelial Cells - Vein, donor1	11267-116G7	34.13	4.55	0.00	0.00	2.28	0.00	0.00	2.28	1.14	0.00
Endothelial Cells - Vein, donor2	11344-117G3	55.88	2.79	0.70	0.00	3.49	0.00	0.00	0.70	0.00	0.70
Endothelial Cells - Vein, donor3	11416-118F3	32.81	2.36	3.30	1.10	1.88	0.16	0.00	1.57	0.16	1.10
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	1.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	1.95	10.26	2.44	3.91	0.00	2.69	2.93	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	0.00	6.24	2.08	2.08	0.00	6.24	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	16.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	24.22	4.11	3.69	0.82	1.23	0.00	0.00	1.64	1.23	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	4.60	0.33	1.53	0.33	0.33	0.11	0.00	0.11	0.11	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	9.32	3.79	2.82	0.65	0.22	0.54	0.11	0.22	0.00	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	17.71	2.18	2.55	0.61	0.61	0.12	0.00	0.49	0.12	0.49
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	35.48	1.64	4.23	0.82	2.87	0.27	0.00	0.96	0.27	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	14.87	1.69	3.59	0.21	0.42	0.21	0.00	0.63	0.53	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	18.71	5.01	2.63	1.05	1.05	0.53	0.26	1.05	0.79	0.79
Fibroblast - Aortic Adventitial, donor3	11401-118D6	17.94	2.33	2.99	0.33	0.00	0.00	0.00	1.00	0.00	0.33
Fibroblast - Cardiac, donor1	11268-116G8	22.23	0.91	3.18	1.81	0.45	0.00	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	20.46	0.00	0.00	0.00	0.76	0.00	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	14.67	0.63	1.58	0.47	0.63	0.00	0.16	1.10	0.00	0.32
Fibroblast - Cardiac, donor4	11452-119A3	25.76	1.52	5.46	1.21	3.94	0.61	0.00	0.91	0.00	0.61
Fibroblast - Cardiac, donor5	11456-119A7	24.62	3.05	3.17	1.02	1.52	0.63	0.00	1.02	1.02	0.76
Fibroblast - Cardiac, donor6	11460-119B2	16.83	1.36	2.12	1.21	1.06	0.00	0.15	0.45	1.06	0.45
Fibroblast - Choroid Plexus, donor1	11492-119E7	84.55	5.09	2.55	0.54	2.28	1.07	0.13	0.13	1.07	4.15
Fibroblast - Choroid Plexus, donor2	11572-120E6	72.48	0.00	0.86	0.43	1.73	0.43	0.00	0.86	1.29	3.02
Fibroblast - Choroid Plexus, donor3	11653-122E6	48.34	1.46	2.93	0.00	1.46	0.00	0.00	0.00	0.00	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	8.76	5.07	2.31	0.23	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	21.54	8.48	3.73	0.51	1.53	1.36	0.51	0.17	0.00	0.34
Fibroblast - Dermal, donor1	11269-116G9	12.91	0.94	1.88	0.00	0.00	0.00	0.00	0.94	0.47	0.00
Fibroblast - Dermal, donor2	11346-117G5	16.51	2.83	1.42	0.00	0.00	0.00	0.00	0.47	0.00	0.47
Fibroblast - Dermal, donor3	11418-118F5	11.48	1.81	1.21	0.48	0.24	0.12	0.12	0.24	0.24	0.12
Fibroblast - Dermal, donor4	11450-119A1	6.67	1.36	2.15	0.90	0.23	0.11	0.00	0.00	0.00	0.00
Fibroblast - Dermal, donor5	11454-119A5	12.56	1.57	1.74	1.92	0.17	0.00	0.00	0.17	0.00	0.00
Fibroblast - Dermal, donor6	11458-119A9	13.64	1.30	2.11	0.97	0.65	0.00	0.00	0.16	0.32	0.00
Fibroblast - Gingival, donor1	11237-116D4	12.91	1.67	2.50	0.42	0.21	0.00	0.00	0.62	0.62	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	12.05	7.34	2.62	0.52	0.52	0.26	0.26	0.26	0.26	0.26
Fibroblast - Gingival, donor2	11318-117D4	12.78	2.11	1.71	0.53	0.53	0.00	0.00	0.40	0.40	0.13
Fibroblast - Gingival, donor3	11394-118C8	14.89	4.35	3.77	0.77	0.00	0.58	0.10	0.77	0.10	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	21.82	2.08	3.12	2.08	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	23.44	1.94	3.35	0.53	1.06	0.18	0.00	0.70	0.35	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	13.87	0.94	3.90	1.40	0.94	0.00	0.00	0.31	0.16	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	13.39	0.68	1.62	0.27	0.41	0.00	0.00	0.14	0.00	0.27
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	9.53	0.00	3.53	0.71	0.35	0.00	0.00	2.12	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	17.11	0.88	3.22	0.88	1.17	0.00	0.00	0.44	0.15	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	16.91	2.45	3.68	0.41	0.68	0.00	0.00	0.95	0.41	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	20.84	1.10	1.65	1.21	1.21	0.11	0.11	0.55	0.77	0.22
Fibroblast - Gingival, donor9 (control)	11927-125I1	31.84	3.96	2.93	1.17	0.59	0.44	0.29	0.44	0.29	0.44
Fibroblast - Lung, donor1	11270-116H1	10.87	0.00	1.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	10.45	0.00	1.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	10.55	0.42	0.42	0.00	0.21	0.00	0.00	0.00	0.42	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	19.99	0.00	1.67	0.00	0.00	0.00	0.00	0.83	0.00	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	15.38	1.40	2.80	1.40	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	10.92	0.28	2.52	0.28	1.12	0.00	0.00	0.56	0.28	0.28
Fibroblast - Mammary, donor1	11540-120B1	23.14	2.44	1.62	1.62	0.00	0.00	0.00	0.41	0.00	0.41
Fibroblast - Mammary, donor2	11620-122A9	15.98	3.99	7.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	17.87	5.96	0.00	5.96	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	9.31	2.13	1.36	1.16	0.39	0.39	0.00	0.19	0.19	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	13.35	3.03	3.64	1.37	0.30	0.15	0.00	0.30	0.30	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	11.63	0.92	2.14	0.61	0.31	0.00	0.00	0.61	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	14.12	1.14	2.67	0.76	0.38	0.00	0.00	1.53	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	13.50	2.43	2.43	1.08	0.27	0.27	0.00	0.81	0.27	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	26.56	4.18	4.52	0.58	0.58	0.35	0.00	1.39	0.35	0.93
Fibroblast - Pulmonary Artery, donor1	11250-116E8	17.91	0.77	1.55	0.77	0.88	0.00	0.11	0.44	0.66	0.33
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	12.60	1.02	1.42	0.81	0.00	0.00	0.20	0.00	0.20	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	9.35	6.01	4.68	2.00	0.67	0.67	0.00	0.67	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	7.51	3.56	1.58	0.40	0.00	0.79	0.00	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	21.43	5.16	2.38	1.59	1.19	0.40	0.00	1.59	0.79	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	17.41	3.55	2.66	0.89	0.36	0.53	0.36	0.36	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	14.19	6.31	2.37	1.18	0.20	1.38	0.59	0.20	0.00	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	15.95	2.71	3.01	1.50	1.20	0.30	0.00	0.30	2.11	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	13.17	2.37	3.99	0.65	0.54	0.22	0.11	0.32	0.11	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	22.02	4.05	2.28	1.77	1.01	0.00	0.25	0.76	1.52	0.25
Fibroblast - skin normal, donor1	11553-120C5	12.31	3.77	3.12	0.49	0.49	0.82	0.33	0.49	0.16	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	46.92	1.80	2.01	1.00	4.41	0.20	0.20	0.60	0.00	1.20
Fibroblast - skin normal, donor2	11561-120D4	22.60	6.33	4.02	1.61	1.11	0.60	0.40	0.60	0.50	0.30
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	25.09	5.14	4.53	1.81	0.30	0.00	0.00	0.60	1.21	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	12.34	5.14	2.98	0.99	0.99	0.91	0.25	0.08	0.08	0.17
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	21.03	5.47	3.08	0.34	0.68	0.51	0.17	0.00	0.85	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	24.96	0.99	2.96	0.00	0.66	0.00	0.00	0.33	1.31	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	14.17	0.96	2.13	1.17	0.00	0.11	0.21	0.43	0.32	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	18.22	1.69	1.52	2.36	0.34	0.34	0.00	0.67	0.17	0.51
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	12.55	2.35	1.41	0.63	0.78	0.47	0.63	0.94	0.31	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	44.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	11.33	25.27	0.87	1.74	0.00	6.97	1.74	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	9.71	8.15	5.72	2.43	0.35	1.91	0.87	0.35	0.17	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	8.59	7.29	5.73	1.04	0.26	1.82	0.26	0.26	0.26	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	7.92	10.48	4.09	2.30	0.26	2.30	0.77	0.26	0.51	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	14.55	3.06	0.00	2.30	0.00	0.00	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	29.99	1.28	1.91	2.55	0.64	0.64	0.64	0.00	0.64	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	59.05	2.85	2.28	3.71	3.14	0.57	0.86	0.00	0.57	2.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	51.57	4.41	12.96	4.96	6.89	0.00	0.00	0.00	0.55	2.76
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	55.48	5.94	5.94	2.51	6.62	0.46	0.23	0.00	0.91	1.83
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	38.83	0.79	4.16	4.36	1.59	1.19	0.00	0.00	0.40	1.19
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	46.79	2.11	8.46	6.61	8.19	0.26	0.79	0.00	0.26	1.85
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	48.60	4.57	8.48	3.59	8.48	0.98	0.33	0.00	0.65	2.94
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	38.92	3.10	0.44	3.10	0.44	1.77	1.33	0.00	0.44	1.77
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	26.57	2.26	0.57	3.11	1.27	0.28	1.13	0.00	0.14	1.13
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	37.93	2.34	1.35	3.32	1.35	0.25	0.62	0.12	0.12	1.35
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	21.22	4.03	1.07	1.61	1.61	1.07	0.54	0.00	0.00	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	49.06	1.12	2.48	5.08	1.73	0.12	0.25	0.00	0.12	2.73
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	53.02	3.32	3.18	5.12	1.66	0.83	0.83	0.00	0.69	2.77
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	25.21	2.03	1.42	2.85	1.02	0.41	0.41	0.00	0.61	0.81
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	52.25	3.65	4.11	2.28	2.51	0.46	0.68	0.46	2.28	3.42
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	47.09	3.86	3.36	3.74	1.62	0.62	1.12	0.00	0.25	1.99
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	38.91	2.84	1.53	5.25	0.66	0.87	0.87	0.00	0.44	2.84
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	51.41	2.95	2.66	3.25	3.25	0.30	0.00	0.30	0.59	2.95
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	64.70	3.50	4.29	3.34	3.50	0.48	1.43	0.16	0.32	2.38
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	30.61	3.80	3.13	3.13	1.56	0.22	0.22	0.00	0.67	2.01
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	54.04	4.03	5.85	4.23	3.02	0.20	0.20	0.40	0.81	3.02
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	65.65	3.90	5.26	3.56	3.05	0.17	1.19	0.51	0.17	3.56
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	54.53	4.88	4.88	2.48	3.64	0.71	0.27	0.09	0.80	2.75
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	62.54	4.58	5.62	3.12	3.85	0.62	1.04	0.62	0.73	3.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	64.89	6.32	5.46	2.90	2.05	1.20	0.51	0.34	0.17	3.24
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	64.40	2.77	4.65	3.43	2.66	0.44	0.66	0.55	0.33	3.65
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	43.26	4.08	3.83	2.50	3.24	0.50	0.58	0.25	0.92	2.66
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	46.76	3.88	2.86	2.65	2.25	0.61	0.20	0.00	0.20	1.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	50.34	3.30	5.16	3.30	2.68	0.62	1.24	1.24	0.41	2.48
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	66.18	4.96	6.69	3.92	3.00	0.92	1.38	0.12	1.27	3.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	47.53	6.34	3.34	1.83	2.50	0.67	1.00	0.33	1.17	2.84
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	46.73	3.75	2.87	3.31	5.29	0.00	0.88	0.66	0.88	1.98
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	68.01	3.32	5.90	3.32	2.09	0.49	0.37	0.49	0.74	2.71
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	47.82	4.21	6.48	2.27	2.43	0.97	0.81	0.32	0.81	1.62
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	66.71	3.85	6.41	2.89	2.89	0.64	0.64	0.32	1.92	2.25
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	63.30	4.26	6.35	4.17	2.56	0.28	0.57	0.57	0.47	3.51
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	42.71	7.12	6.01	3.32	2.37	0.32	0.16	0.16	0.47	2.69
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	83.32	3.65	6.99	1.22	4.56	0.30	0.30	0.91	1.22	3.04
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	66.70	4.60	5.65	1.99	2.61	0.52	0.42	1.36	0.73	1.67
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	41.94	4.39	5.71	1.10	3.07	0.00	0.66	0.22	1.10	2.20
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	67.05	2.81	3.65	2.24	4.21	0.00	0.00	1.40	1.40	1.12
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	73.79	2.22	8.15	3.70	2.78	0.09	0.28	1.85	0.28	3.15
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	40.65	1.60	6.42	5.08	1.34	0.00	0.27	0.27	0.80	2.67
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	67.78	1.53	5.05	3.37	3.37	0.00	0.46	2.45	0.61	2.30
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	60.23	2.85	7.38	4.27	0.91	0.26	0.26	2.07	0.26	2.46
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	29.28	1.63	10.57	2.17	1.08	0.27	0.27	0.27	1.08	1.90
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	61.20	2.95	9.03	3.32	3.87	0.18	0.55	1.47	1.29	2.95
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	55.27	1.97	6.14	2.19	2.85	0.00	0.00	2.19	1.10	3.51
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	51.57	0.99	10.91	0.99	2.98	0.00	0.99	0.00	0.99	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	40.76	2.51	5.54	1.98	1.98	0.26	0.26	1.85	0.26	1.45
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	40.35	2.42	3.43	2.22	1.82	0.00	0.40	2.22	0.40	2.02
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	67.61	5.08	10.17	4.83	6.61	0.25	0.25	1.27	1.52	1.52
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	14.13	1.59	0.80	3.98	1.00	1.19	1.00	0.00	0.40	0.40
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	20.34	0.92	0.92	2.47	1.08	0.62	0.77	0.00	0.15	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	25.98	2.05	1.23	4.30	1.23	0.61	0.82	0.00	0.00	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	16.90	1.25	0.63	2.50	3.44	0.63	0.31	0.00	0.31	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	16.95	0.85	1.70	2.54	0.28	0.28	0.57	0.00	0.28	1.13
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	17.06	2.31	0.46	0.46	1.38	0.46	0.46	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	27.22	0.00	4.95	4.95	2.47	0.00	0.00	0.00	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	32.11	4.25	1.16	2.32	1.93	0.00	0.39	0.00	2.71	1.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	17.65	8.02	1.60	3.21	3.21	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	43.47	5.22	3.48	1.74	1.74	1.74	1.74	0.00	1.74	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	27.01	2.28	1.63	2.93	2.60	0.33	0.98	0.00	1.95	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	40.36	2.06	3.29	4.12	1.24	0.82	0.00	0.00	1.24	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	33.32	0.00	0.00	6.66	3.33	0.00	0.00	0.00	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	36.91	1.96	1.96	1.68	2.24	0.28	0.28	0.00	1.12	1.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	29.09	2.94	2.61	1.31	1.63	0.98	0.00	0.00	0.98	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	38.59	0.84	1.68	2.52	2.52	0.00	0.84	0.00	2.52	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	40.71	4.77	2.86	1.91	3.50	0.64	0.00	0.00	1.27	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	32.95	2.38	2.38	2.72	1.70	0.68	0.34	0.00	1.02	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	37.59	2.09	2.09	2.09	6.26	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	51.54	2.86	2.29	2.29	3.44	0.00	0.57	0.00	2.29	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	28.41	2.96	2.07	2.37	2.37	0.30	0.30	0.00	1.48	0.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	42.35	0.00	0.00	3.39	5.08	0.00	0.00	0.00	3.39	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	39.76	4.56	2.49	0.83	2.49	0.00	0.00	0.00	1.24	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	41.42	2.07	2.30	1.84	3.68	0.23	0.00	0.00	1.61	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	26.34	5.27	5.27	0.00	5.27	0.00	0.00	0.00	5.27	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	39.59	6.15	1.54	3.46	2.69	0.00	0.77	0.00	1.92	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	32.27	5.54	1.63	2.28	2.61	0.98	0.00	0.00	0.98	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	32.10	1.34	0.67	2.68	1.34	0.00	0.67	0.00	0.67	3.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	42.38	3.47	3.85	6.16	3.08	0.00	0.00	0.00	0.77	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	48.27	4.11	4.45	1.71	2.74	1.03	0.00	0.00	2.05	2.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	39.76	9.94	4.97	9.94	4.97	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	50.02	3.30	3.30	1.89	0.94	0.47	0.94	0.00	1.89	1.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	36.81	3.62	4.22	1.81	1.21	0.00	0.60	0.00	1.21	1.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	54.43	6.61	7.12	5.60	5.60	0.00	1.02	0.00	1.02	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	39.49	4.79	3.59	1.99	3.99	0.80	0.40	0.00	1.20	2.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	46.38	3.95	0.99	1.48	2.47	0.49	0.49	0.00	3.45	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	92.07	5.90	5.90	4.72	1.18	0.00	0.00	0.00	7.08	3.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	43.76	3.50	2.33	1.75	4.67	0.00	0.00	0.00	2.92	3.50
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	56.18	3.07	3.51	2.63	1.32	0.44	0.44	0.00	2.19	3.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	59.34	7.63	3.39	1.70	1.70	1.70	0.85	0.00	0.85	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	53.13	3.58	2.98	1.79	3.58	0.00	0.00	0.00	4.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	35.42	5.82	5.34	2.43	0.97	0.00	0.00	0.00	1.46	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	18.26	1.14	0.00	0.00	1.14	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	8.32	3.33	2.08	0.00	1.25	0.42	0.42	0.00	1.66	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	21.36	2.25	2.25	1.12	0.00	0.00	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	10.78	3.49	2.85	0.00	0.32	0.00	0.00	0.00	0.32	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	7.52	1.25	0.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	9.17	7.43	0.93	0.81	0.00	0.81	0.00	0.23	0.23	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	13.50	6.92	1.52	1.35	0.34	0.51	0.17	0.51	0.00	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	9.56	5.92	0.68	0.91	0.00	0.68	0.23	0.23	0.23	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	11.48	6.67	0.87	1.97	0.11	0.98	0.77	0.22	0.44	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	12.68	9.24	0.86	0.86	0.86	0.86	0.64	0.21	0.21	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	10.33	5.17	0.86	0.65	0.22	0.86	0.65	0.22	0.22	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	8.72	6.48	1.49	1.00	0.50	1.25	0.62	0.37	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	10.64	5.49	1.37	0.51	0.34	1.20	0.17	0.17	0.00	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	8.01	4.81	0.00	0.32	0.00	0.96	0.64	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	20.71	3.92	6.16	1.68	0.00	0.00	0.00	2.80	1.12	1.12
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	39.38	3.46	1.73	0.43	1.30	0.00	0.00	0.43	0.43	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	37.01	5.29	2.64	0.00	2.64	0.00	0.00	7.93	5.29	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	19.05	3.53	4.94	2.82	0.71	0.00	0.71	0.00	0.00	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	29.06	5.09	4.36	1.45	1.45	0.00	0.00	0.73	0.73	1.45
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	15.04	0.17	1.57	0.52	1.40	0.17	0.17	0.70	1.05	0.00
Hepatocyte, donor1	11523-119I2	12.11	15.74	2.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	8.62	4.31	0.00	0.00	0.00	1.08	1.08	0.00	1.08	0.00
Hepatocyte, donor3	11684-122I1	10.43	3.68	1.23	3.07	1.23	0.61	0.61	0.00	0.61	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	68.53	0.65	0.65	0.00	1.96	0.00	0.00	0.00	0.65	4.57
Intestinal epithelial cells (polarized), donor1	11246-116E4	6.99	10.84	6.99	2.10	0.70	3.15	2.62	0.00	0.00	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	25.52	2.33	2.47	0.27	0.96	0.00	0.00	0.27	0.14	0.41
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	9.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	6.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	5.54	1.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	10.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	15.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	9.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	8.12	0.00	0.00	0.00	1.62	0.00	0.00	0.00	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	8.34	0.00	1.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	3.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	5.29	1.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	4.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	10.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	7.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	1.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	11.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	6.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	8.96	0.00	0.00	0.00	0.81	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	7.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	4.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	6.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	0.00	0.00	15.08	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	2.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	4.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	4.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	8.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	8.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	3.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	11.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	6.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	5.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	8.78	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	6.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	4.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	11.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	12.97	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	13.95	0.00	0.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	2.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	3.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	5.33	0.00	1.07	0.00	1.07	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	6.93	1.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	5.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	8.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	3.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	18.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	14.80	1.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	6.12	9.63	3.26	1.80	0.24	4.57	1.06	0.00	0.16	0.00
Keratinocyte - epidermal, donor2	11349-117G8	2.34	6.44	0.59	1.76	0.00	1.76	0.59	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	1.99	8.24	2.27	2.27	0.00	1.33	1.23	0.00	0.09	0.00
Keratinocyte - oral, donor1	11251-116E9	4.99	12.49	5.90	3.52	0.11	3.97	2.95	0.00	0.00	0.00
Keratocytes, donor1	11527-119I6	17.88	11.35	3.44	0.00	0.00	0.00	0.00	0.34	0.69	0.34
Keratocytes, donor2	11607-120I5	15.23	2.34	1.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	12.05	11.66	1.78	0.20	0.00	0.79	0.20	0.20	0.20	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	28.57	74.73	2.20	8.79	0.00	6.59	2.20	4.40	2.20	0.00
Lens Epithelial Cells, donor1	11529-119I8	24.81	0.00	0.00	2.16	0.00	0.00	1.08	0.00	2.16	1.08
Lens Epithelial Cells, donor2	11609-120I7	40.48	2.54	9.92	1.15	2.08	0.00	0.00	0.00	0.81	0.69
Lens Epithelial Cells, donor3	11690-122I7	40.57	0.71	2.22	0.10	1.82	0.10	0.10	0.61	0.61	2.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	26.32	6.88	4.15	1.30	2.85	1.07	0.24	1.07	0.12	0.36
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	15.63	5.58	2.23	0.56	0.28	0.00	0.28	0.84	0.84	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	22.98	9.29	3.15	1.26	2.05	1.73	0.16	1.26	1.10	0.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	16.67	5.38	1.61	1.61	0.54	1.61	0.00	1.08	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	16.39	5.99	3.47	2.21	1.58	1.89	0.63	0.95	0.95	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	19.84	5.39	2.70	1.40	1.62	1.29	0.65	0.97	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	16.83	6.16	3.69	2.46	2.46	1.23	1.64	0.41	0.82	1.23
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	14.16	5.31	3.79	1.77	1.77	1.77	0.25	0.25	0.76	0.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	15.90	5.91	2.53	0.99	1.55	1.69	0.00	1.41	0.70	0.42
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	17.01	5.93	0.79	0.40	1.19	1.58	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	19.19	6.79	3.30	2.71	1.94	1.74	0.19	0.58	0.78	0.78
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	14.26	5.55	1.85	1.67	1.11	0.37	0.00	0.74	0.93	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	17.77	6.62	5.23	0.35	1.74	1.05	0.00	0.00	0.00	0.70
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	12.64	5.96	4.05	0.48	1.43	1.19	0.24	0.72	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	15.11	3.30	3.16	1.24	1.51	1.51	0.27	1.10	1.24	0.41
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	15.71	6.78	3.39	1.54	1.23	1.85	0.00	0.92	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	15.28	4.05	2.18	1.87	0.94	0.00	0.00	0.62	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	19.58	6.04	2.38	2.01	2.20	2.01	0.73	0.55	0.73	0.73
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	16.46	5.27	2.63	0.99	0.33	0.99	0.33	0.33	0.66	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	16.40	2.93	4.10	1.46	2.34	0.00	0.29	0.88	0.59	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	22.15	3.73	1.74	1.74	2.49	1.00	0.00	0.25	0.75	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	18.91	5.82	2.91	0.48	0.48	0.97	0.48	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	19.93	4.04	2.42	1.62	2.69	1.08	0.81	0.81	1.35	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	18.62	5.45	2.42	0.61	2.57	1.36	0.15	0.45	1.67	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	16.59	3.63	2.07	0.52	0.00	0.00	0.00	1.56	1.04	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	16.96	5.23	3.56	1.26	1.68	1.26	0.00	0.63	0.84	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	18.35	4.81	4.21	1.05	1.95	1.80	0.15	0.75	0.90	0.45
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	21.32	6.88	0.00	1.38	2.06	0.69	0.69	1.38	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	14.30	5.83	3.39	0.94	0.94	1.32	0.19	0.56	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	14.10	5.51	2.76	0.95	0.95	0.95	0.42	1.17	0.74	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	9.21	5.33	1.94	1.94	1.45	0.97	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	16.21	2.65	1.32	1.98	0.99	1.65	0.00	0.99	0.66	0.99
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	14.12	4.83	3.72	0.74	1.86	0.87	0.25	1.36	0.99	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	21.84	9.26	3.70	0.74	0.74	4.07	0.37	0.37	0.37	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	17.05	6.18	2.47	0.49	0.49	1.48	0.25	0.49	0.74	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	15.26	4.54	2.34	1.10	0.96	1.92	0.55	0.82	0.27	0.55
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	19.62	5.47	1.93	2.25	0.64	0.96	0.64	0.32	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	21.00	7.61	3.04	0.91	2.13	2.43	0.00	0.61	0.91	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	19.60	4.76	2.80	1.54	1.26	2.66	0.00	0.70	0.70	0.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	15.29	7.11	3.56	2.49	0.36	1.07	0.00	0.71	0.36	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	11.63	5.82	2.42	0.00	0.97	1.94	0.48	0.48	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	13.85	3.89	2.33	0.93	1.09	1.24	0.00	0.47	1.09	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	15.76	4.66	2.51	1.79	1.43	0.00	0.00	0.36	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	14.37	7.51	3.27	1.31	1.63	1.63	0.33	0.98	0.98	1.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	12.95	3.53	2.12	1.41	0.71	0.94	0.24	0.24	0.47	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	24.63	5.82	1.98	1.11	1.11	1.24	0.37	0.62	0.25	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	12.81	4.87	1.54	1.02	1.28	1.28	0.00	0.77	0.51	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	17.60	5.67	2.98	0.60	0.90	1.79	0.30	0.30	1.19	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	15.86	20.39	2.27	0.00	0.00	0.00	2.27	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	12.27	19.18	2.30	1.53	0.00	3.84	0.77	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	12.62	13.36	2.97	0.00	0.00	1.48	3.71	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	17.77	19.04	2.96	1.69	0.00	2.12	2.54	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	13.36	17.58	2.11	1.41	0.70	2.11	2.11	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	8.41	24.28	1.87	0.93	0.00	2.80	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	15.97	21.13	3.09	0.52	0.00	2.58	0.52	0.00	0.52	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	11.89	14.27	3.57	0.00	0.00	3.57	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	14.70	16.74	3.17	1.13	0.00	3.62	2.26	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	13.96	16.58	2.91	2.62	0.00	3.49	0.58	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	11.25	21.16	2.70	1.80	0.00	2.70	1.35	0.00	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	18.02	18.97	4.47	1.49	0.14	4.61	3.12	0.00	0.54	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	23.62	19.00	2.05	0.51	0.51	2.57	1.54	0.51	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	13.06	23.99	5.65	0.71	0.71	2.47	0.71	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	15.99	21.99	1.33	2.00	0.67	1.33	2.00	0.00	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	26.49	17.32	6.11	2.04	0.00	2.04	1.02	0.00	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	14.41	19.48	2.93	1.87	0.00	2.67	2.13	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	13.98	20.78	4.72	1.51	0.38	4.16	2.08	0.00	0.38	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	17.18	17.18	5.52	0.61	0.00	5.52	1.23	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	13.05	22.83	2.45	0.82	0.00	7.34	5.71	0.00	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	12.29	17.28	3.54	1.67	0.00	4.16	2.08	0.00	0.62	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	15.97	17.10	2.52	1.40	0.00	2.24	1.68	0.00	0.56	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	15.46	13.39	4.12	2.06	0.00	3.09	3.09	0.00	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	14.81	18.00	4.06	1.16	0.58	2.61	2.03	0.00	0.87	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	19.73	16.44	2.99	0.30	0.00	2.39	0.30	0.00	0.60	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	16.04	17.15	2.77	1.66	0.55	2.21	2.21	0.00	1.11	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	15.91	24.74	3.53	1.77	0.35	4.24	1.06	0.00	0.71	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	19.55	20.65	3.32	0.37	0.74	1.84	1.11	0.00	1.11	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	26.48	11.51	3.45	1.15	0.00	1.15	0.00	0.00	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	22.64	15.73	5.37	1.54	0.38	2.30	1.54	0.00	0.77	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	22.08	18.12	3.40	0.57	0.00	1.70	1.70	0.00	0.57	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	19.69	18.87	4.10	2.46	0.00	2.46	0.00	0.00	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	14.01	18.08	4.07	0.45	0.45	0.90	1.81	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	26.57	18.67	5.75	2.15	0.72	1.44	0.00	0.00	1.44	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	17.93	20.91	7.47	1.49	0.75	0.75	0.75	0.00	0.75	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	24.15	21.18	4.83	1.86	0.00	4.09	0.74	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	27.57	19.38	3.88	0.43	0.00	3.45	0.43	0.00	0.43	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	17.13	21.41	1.71	0.86	0.00	0.86	2.57	0.00	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	22.32	18.66	2.33	1.00	0.67	2.00	2.33	0.00	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	19.31	19.91	1.81	1.81	0.00	3.62	1.81	0.00	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	12.09	23.46	2.84	0.00	0.00	2.84	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	22.00	17.19	1.72	2.41	0.00	2.41	2.41	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	32.74	16.10	2.68	1.61	0.00	2.15	1.07	0.00	0.54	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	14.14	12.12	1.35	1.35	0.00	2.02	0.67	0.00	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	16.30	22.59	4.44	2.22	0.74	3.70	1.85	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	15.12	10.47	3.49	1.16	1.16	1.16	1.16	0.00	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	11.64	16.92	4.23	2.12	0.00	4.23	3.17	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	22.41	19.21	2.00	2.40	0.40	4.80	2.00	0.00	0.40	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	26.89	26.89	3.63	0.73	0.73	3.63	2.18	0.00	0.00	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	15.33	20.70	6.13	3.83	0.00	4.60	0.77	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	20.72	21.70	4.93	3.45	0.49	3.45	2.47	0.00	0.49	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	23.52	16.94	2.82	4.70	0.00	3.76	0.94	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	18.10	20.11	4.53	2.51	1.01	4.02	1.51	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	19.38	22.53	4.51	0.00	0.00	3.15	1.35	0.00	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	36.14	15.49	1.72	0.00	0.00	5.16	3.44	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	14.25	22.71	4.01	2.23	0.00	2.23	2.67	0.00	0.00	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	18.38	24.63	3.52	2.35	0.00	2.74	2.35	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	23.75	21.77	4.62	0.66	0.66	2.64	2.64	0.00	0.00	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	21.79	20.24	2.08	1.56	0.00	1.04	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	17.07	22.75	2.63	0.44	0.88	2.19	1.31	0.00	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	24.04	17.89	2.80	1.68	0.56	6.15	1.68	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	18.55	14.57	1.77	2.21	0.00	4.42	1.32	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	16.97	18.51	3.47	1.93	0.00	3.86	1.93	0.00	0.39	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	17.72	24.81	1.01	0.51	0.00	4.05	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	10.09	26.43	4.33	0.48	0.00	3.84	1.92	0.00	0.48	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	19.48	25.05	1.99	1.59	0.00	1.99	0.40	0.00	0.80	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	23.09	17.01	1.22	1.82	0.00	3.65	1.82	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	11.76	14.53	1.38	2.08	0.00	0.00	2.08	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	16.72	20.14	3.04	0.76	0.00	3.04	0.76	0.00	0.38	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	26.34	19.62	3.10	3.61	0.52	2.58	1.03	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	8.47	18.14	3.63	1.21	0.00	3.02	1.81	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	20.60	19.33	2.54	1.27	0.00	3.17	3.17	0.00	0.32	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	46.38	25.06	2.13	2.13	0.53	2.13	0.53	0.00	1.07	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	22.41	16.67	4.02	0.00	0.00	1.15	0.00	0.00	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	38.05	15.43	4.11	2.06	0.00	2.57	1.03	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	39.61	26.17	4.24	0.71	0.71	2.12	0.71	0.00	0.71	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	22.70	14.75	2.84	2.27	0.00	0.00	1.70	0.00	1.13	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	29.12	19.97	5.41	0.42	0.00	3.33	2.08	0.00	0.42	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	42.28	16.44	0.78	0.00	0.00	2.35	2.35	0.00	0.78	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	23.38	16.28	1.25	1.67	0.00	1.67	0.00	0.00	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	33.45	19.98	1.86	1.86	0.00	3.25	2.79	0.00	0.93	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	52.85	21.41	2.68	2.68	0.00	2.01	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	28.87	20.85	2.14	1.07	0.00	1.07	2.67	0.00	0.53	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	38.79	23.44	2.02	0.00	0.40	2.42	2.02	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	43.13	27.53	1.84	1.84	0.00	1.84	0.92	0.00	1.84	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	24.01	19.56	3.56	0.89	0.00	1.78	1.78	0.00	0.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	34.76	38.18	4.56	0.57	0.57	1.71	2.28	0.00	0.57	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	36.81	26.84	2.30	0.00	0.00	3.07	0.00	0.00	0.00	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	31.74	24.08	1.64	1.64	0.00	0.55	1.64	0.00	1.64	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	43.65	25.84	3.12	2.23	0.45	1.34	2.23	0.00	0.45	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	49.65	27.04	3.12	1.30	0.26	3.38	1.04	0.00	0.00	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	32.49	21.22	3.32	1.33	0.66	1.33	2.65	0.00	1.33	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	37.41	33.26	8.31	2.08	2.08	0.00	0.00	0.00	2.08	2.08
Macrophage - monocyte derived, donor1	11232-116C8	32.59	1.37	2.28	0.68	1.14	0.00	0.00	0.00	0.91	0.46
Macrophage - monocyte derived, donor2	11313-117C8	23.12	0.55	2.02	0.00	0.37	0.00	0.00	0.00	0.55	0.00
Macrophage - monocyte derived, donor3	11389-118C3	27.92	1.31	3.15	1.57	1.05	0.00	0.00	0.00	0.13	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	6.90	5.31	4.78	2.12	0.00	2.12	0.53	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	11.57	4.60	7.13	1.58	0.00	1.90	0.79	0.00	0.00	0.00
Mallassez-derived cells, donor3	11930-125I4	7.92	6.67	5.28	0.83	0.14	1.53	0.14	0.28	0.14	0.00
Mammary Epithelial Cell, donor1	11273-116H4	2.69	10.76	2.29	2.99	0.00	1.89	1.89	0.00	0.10	0.00
Mammary Epithelial Cell, donor2	11350-117G9	3.47	6.08	1.16	2.32	0.00	1.74	1.45	0.00	0.29	0.00
Mammary Epithelial Cell, donor3	11422-118F9	3.74	4.99	2.99	2.24	0.25	0.50	0.25	0.25	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	42.03	0.00	2.71	1.36	0.00	0.00	0.00	0.00	0.68	1.36
Mast cell, donor1	11563-120D6	33.20	1.41	4.22	0.32	0.54	0.22	0.00	0.00	0.32	0.00
Mast cell, donor2	11565-120D8	34.77	4.75	5.94	1.19	0.59	0.30	0.89	0.00	0.00	0.00
Mast cell, donor3	11566-120D9	42.55	6.53	6.30	4.50	0.90	0.45	0.23	0.00	0.45	0.00
Mast cell, donor4	11567-120E1	32.62	5.85	7.27	3.19	0.35	0.00	0.00	0.00	0.18	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	63.54	1.11	2.11	1.00	0.33	0.00	0.22	0.00	0.55	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	70.04	2.33	2.92	0.00	0.58	0.58	0.00	0.00	0.58	0.58
Mast cell, expanded, donor5	11939-126A4	40.50	0.34	4.02	0.92	0.11	0.00	0.00	0.00	1.03	0.00
Mast cell, expanded, donor8	11941-126A6	36.15	2.85	4.35	1.17	0.84	0.17	0.33	0.00	0.67	0.00
Melanocyte - dark, donor1	11502-119F8	22.29	10.65	3.38	1.89	1.89	1.79	0.30	0.40	0.99	0.30
Melanocyte - dark, donor2	11582-120F7	17.65	1.04	3.81	0.35	0.69	0.00	0.00	0.00	0.00	1.04
Melanocyte - dark, donor3	11663-122F7	22.46	5.94	9.49	2.25	1.09	0.07	0.29	0.87	0.80	0.22
Melanocyte - light, donor1	11274-116H5	27.74	4.70	9.40	2.82	1.65	0.00	0.47	0.71	0.71	0.71
Melanocyte - light, donor2	11351-117H1	12.97	1.36	4.78	0.00	1.36	0.00	0.00	1.36	0.00	0.00
Melanocyte - light, donor3	11423-118G1	13.88	4.34	4.34	0.87	1.73	0.00	0.00	0.00	0.87	1.73
Melanocyte, donor1 (MC+1)	12641-134G4	39.57	7.91	7.50	3.75	1.25	0.52	1.35	1.67	0.10	0.73
Melanocyte, donor2 (MC+2)	12739-135I3	8.88	2.69	2.96	1.88	0.81	0.27	0.54	0.81	0.81	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	23.57	3.21	5.62	0.80	0.27	0.00	0.00	0.54	0.00	0.27
Meningeal Cells, donor1	11493-119E8	29.77	3.10	2.23	1.12	0.25	0.00	0.25	0.37	0.62	1.36
Meningeal Cells, donor2	11573-120E7	34.77	2.64	2.20	0.44	0.00	0.88	0.00	0.00	0.00	2.20
Meningeal Cells, donor3	11654-122E7	28.77	1.79	1.79	0.57	0.98	0.08	0.00	0.24	0.49	0.73
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	17.96	0.29	1.14	0.29	1.71	0.00	0.00	1.14	0.57	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	34.72	1.31	2.72	0.30	2.21	0.10	0.00	1.11	0.60	1.41
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	3.94	0.00	1.31	0.00	1.31	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	2.62	0.00	2.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	15.07	0.72	2.87	2.15	0.72	0.00	0.00	0.00	0.72	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	16.73	2.12	1.69	0.64	0.64	0.00	0.85	0.64	0.42	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	12.57	1.51	1.51	1.01	0.00	0.50	0.00	0.50	0.50	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	17.36	0.66	1.32	0.00	0.66	0.00	0.00	0.44	0.00	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	9.50	0.73	0.73	2.19	0.00	0.00	0.00	0.73	1.46	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	16.37	0.41	1.23	0.41	0.41	0.00	0.00	1.02	0.20	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	18.98	1.52	1.94	0.28	0.28	0.00	0.00	0.69	0.69	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	27.88	1.12	3.35	1.49	0.37	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	30.39	1.58	1.84	0.26	1.71	0.00	0.00	0.53	0.39	1.71
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	24.33	0.00	0.30	0.00	1.19	0.00	0.00	1.48	0.30	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	23.36	0.00	2.34	0.00	2.34	0.00	0.00	0.00	0.00	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	26.26	0.00	0.00	0.64	0.64	0.00	0.00	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	13.11	0.71	1.42	0.71	1.06	0.00	0.00	0.00	0.35	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	16.57	1.25	1.25	0.94	0.94	0.00	0.00	0.63	0.31	0.94
Mesenchymal stem cells - umbilical, donor0	11214-116A8	20.32	0.00	0.00	0.00	0.00	0.00	0.00	0.73	0.73	0.73
Mesothelial Cells, donor1	11247-116E5	29.43	1.59	7.69	1.33	2.92	0.27	0.53	0.53	0.80	0.00
Mesothelial Cells, donor2	12156-128G5	20.02	0.50	4.50	0.50	2.00	0.50	0.00	0.00	1.50	0.00
Mesothelial Cells, donor3	11402-118D7	26.81	2.02	9.25	1.73	0.43	0.14	0.07	0.51	0.43	0.07
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	8.10	2.70	2.70	0.00	1.35	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	24.38	1.72	1.97	0.25	1.23	0.00	0.00	0.00	2.22	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	18.55	1.18	5.01	0.88	0.29	0.00	0.00	0.00	0.29	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	3.46	0.00	6.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	18.60	0.62	1.24	0.31	0.62	0.00	0.00	0.00	0.62	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	15.97	0.62	2.49	0.21	1.04	0.00	0.00	0.00	0.41	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	4.63	0.00	4.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	22.77	1.25	1.75	0.25	1.25	0.00	0.00	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	22.81	2.33	4.65	0.47	1.40	0.00	0.00	0.00	0.00	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	21.34	0.61	2.03	0.61	1.02	0.00	0.00	0.00	0.81	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	18.61	0.79	1.19	0.40	1.19	0.00	0.00	0.00	0.00	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	11.50	0.88	0.00	0.00	0.00	0.00	0.00	0.00	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	18.62	1.14	1.90	0.76	1.52	0.00	0.00	0.00	0.00	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	3.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	13.58	0.64	0.85	0.00	0.85	0.00	0.00	0.00	0.42	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	5.52	0.92	2.76	0.92	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	9.84	0.60	1.19	0.00	0.30	0.00	0.00	0.00	0.30	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	5.03	1.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	11.54	0.00	1.25	0.50	0.25	0.00	0.00	0.00	1.00	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	9.03	1.19	2.38	0.24	0.71	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	3.87	0.55	2.76	0.00	0.55	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	8.52	0.23	0.92	0.00	0.00	0.23	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	7.78	0.42	2.10	0.21	0.21	0.00	0.00	0.00	0.42	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	5.30	0.20	0.82	0.00	0.61	0.00	0.00	0.00	0.61	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	7.72	0.21	1.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	6.22	0.22	2.45	0.44	0.22	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	4.16	0.44	0.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	5.07	0.00	1.52	0.51	0.51	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	1.66	1.66	1.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	6.52	0.00	1.09	0.00	0.27	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	8.23	0.88	0.88	0.00	0.29	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	2.18	0.00	1.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	4.81	0.00	0.48	0.00	0.48	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	6.80	0.40	2.40	1.20	1.60	0.40	0.00	0.00	0.00	0.80
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	9.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	12.51	0.00	0.00	0.00	1.50	0.00	0.00	0.00	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	4.08	0.00	6.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	22.77	0.00	0.44	0.00	1.31	0.00	0.00	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	6.62	0.00	1.10	0.00	0.00	0.00	0.00	0.00	4.41	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	15.37	0.64	1.28	0.64	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	22.56	0.00	0.74	0.25	2.98	0.00	0.00	0.00	0.25	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	6.96	0.00	3.48	0.00	0.70	0.00	0.00	0.00	0.00	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	13.26	2.21	4.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	22.91	1.37	0.34	0.00	0.68	0.00	0.00	0.00	0.34	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	14.00	0.00	0.88	0.00	0.00	0.00	0.00	0.00	0.00	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	10.65	0.00	0.36	0.36	0.36	0.00	0.00	0.00	0.00	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	18.52	0.00	0.56	0.28	1.12	0.00	0.00	0.00	0.00	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	12.47	0.42	2.08	0.00	1.25	0.00	0.00	0.00	0.42	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	8.74	1.75	0.58	0.58	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	15.69	0.30	0.00	0.00	1.51	0.00	0.00	0.00	0.00	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	13.36	0.00	0.83	0.42	0.42	0.00	0.00	0.00	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	7.39	0.00	0.92	0.00	0.92	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	13.66	1.71	2.85	0.00	1.14	0.00	0.00	0.00	0.57	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	14.65	1.24	3.59	0.83	0.97	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	18.14	0.26	0.52	0.00	1.04	0.00	0.00	0.00	0.26	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	12.01	0.86	2.57	0.00	0.00	0.00	0.43	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	8.26	0.64	0.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	10.94	0.53	1.07	0.27	0.80	0.00	0.00	0.00	0.00	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	26.64	0.60	0.90	0.30	1.80	0.00	0.00	0.00	0.00	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	15.68	0.42	1.84	0.42	0.00	0.00	0.00	0.00	0.14	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	18.47	0.96	1.27	0.32	1.59	0.00	0.00	0.00	0.96	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	19.24	0.44	2.43	0.88	0.66	0.00	0.00	0.00	0.22	0.44
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	12.89	0.76	2.28	0.38	0.76	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	21.59	0.28	1.14	0.28	2.27	0.00	0.00	0.00	0.00	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	18.44	0.25	1.23	0.00	0.74	0.00	0.00	0.00	0.49	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	13.03	0.65	1.96	0.00	0.65	0.00	0.00	0.00	0.00	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	23.82	0.29	2.06	0.29	0.29	0.00	0.00	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	27.68	0.29	1.73	0.00	1.15	0.00	0.00	0.00	0.00	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	28.03	2.06	1.24	0.82	2.47	0.00	0.00	0.00	0.41	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	21.14	0.89	1.49	0.00	1.49	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	26.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	12.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	36.14	0.00	1.31	0.33	1.97	0.00	0.00	0.00	0.33	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	21.04	0.00	1.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	25.11	0.20	0.99	0.40	2.37	0.00	0.00	0.00	0.40	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	19.56	1.86	0.00	0.93	1.86	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	21.78	1.50	1.88	0.75	0.38	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	19.18	0.27	0.53	0.00	0.80	0.00	0.00	0.00	0.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	22.51	0.45	0.57	0.00	1.36	0.00	0.00	0.00	0.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	22.10	0.00	0.00	0.00	0.74	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	26.38	0.37	1.47	0.00	1.83	0.00	0.00	0.00	0.00	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	17.11	1.56	0.00	0.00	1.56	0.00	0.00	0.00	3.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	12.83	0.00	0.53	0.00	0.53	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	7.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	15.15	1.01	1.01	2.02	1.01	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	7.59	0.00	0.84	0.00	0.42	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	5.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	1.91	0.00	0.64	0.00	0.64	0.00	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	1.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	4.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	5.71	0.00	5.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	13.05	3.26	6.52	0.00	0.00	3.26	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	9.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	37.65	0.00	0.00	0.00	0.00	12.55	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	17.88	6.46	2.80	0.43	0.22	0.22	0.22	1.51	0.22	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	23.52	8.88	1.57	1.57	0.00	1.57	0.00	2.09	0.52	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	34.04	0.67	2.00	0.67	0.67	0.00	0.00	2.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	15.44	1.67	3.34	1.25	0.00	0.00	0.00	0.83	0.00	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	60.47	0.95	1.52	0.00	2.47	0.00	0.00	1.14	0.00	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	62.24	0.00	11.17	1.60	0.00	0.00	0.00	6.38	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	29.24	0.00	2.04	0.68	0.68	0.00	0.00	2.04	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	44.10	0.00	0.00	0.00	5.51	1.84	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	35.99	0.00	1.67	0.42	0.00	0.00	0.00	1.26	0.00	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	31.84	0.46	2.09	0.46	1.16	0.00	0.00	1.16	0.46	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	48.37	0.54	2.70	0.54	2.16	0.00	0.00	1.89	0.00	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	46.46	0.84	3.57	0.63	0.63	0.00	0.21	1.68	0.63	0.63
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	55.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00	11.13	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	46.16	0.50	4.96	0.00	1.99	0.00	0.00	1.49	0.00	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	41.95	1.08	2.71	0.27	1.62	0.00	0.00	1.08	0.54	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	32.19	1.59	5.67	0.23	0.91	0.00	0.23	1.59	0.00	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	33.64	0.82	4.57	0.16	1.47	0.16	0.16	0.82	0.00	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	49.57	0.36	3.65	0.36	2.00	0.00	0.00	1.09	0.91	0.73
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	42.97	1.06	3.18	0.00	1.06	0.00	0.00	2.12	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	34.22	1.20	4.20	1.80	1.80	0.00	0.00	1.20	0.60	1.20
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	73.51	0.00	0.98	0.00	2.95	0.00	0.00	0.33	0.66	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	28.95	1.63	3.90	0.33	0.81	0.49	0.00	0.81	0.16	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	40.57	1.06	5.29	0.35	0.53	0.18	0.00	1.41	0.35	0.88
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	35.16	1.41	3.52	1.41	0.00	0.00	0.00	4.22	0.00	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	36.78	0.92	1.84	0.46	1.38	0.92	0.00	1.38	0.92	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	43.70	0.64	2.25	0.32	1.93	0.00	0.00	1.61	0.00	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	63.46	0.69	2.07	0.00	4.14	0.34	0.00	0.69	0.69	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	93.55	0.00	2.53	0.00	5.06	0.00	0.00	5.06	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	31.19	2.67	4.90	0.67	1.56	0.00	0.00	0.67	0.45	0.67
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	31.75	1.27	2.96	0.85	1.27	0.00	0.42	0.85	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	35.60	1.19	3.09	0.24	0.71	0.00	0.00	1.19	0.24	0.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	58.38	0.43	3.43	0.43	1.72	0.43	0.43	1.72	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	72.22	0.00	0.00	0.00	9.03	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	43.99	0.33	4.67	0.67	1.00	0.33	0.00	1.00	0.33	0.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	23.44	0.00	2.25	0.00	2.25	0.00	0.00	1.35	1.80	1.35
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	34.52	1.59	1.98	0.40	0.79	0.00	0.40	0.40	0.00	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	49.22	3.71	0.00	0.00	2.79	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	45.03	0.76	3.78	0.00	4.16	0.00	0.00	1.89	0.00	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	28.03	4.56	1.96	1.96	0.00	0.33	0.00	0.33	0.00	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	35.73	2.18	7.41	0.44	0.87	0.44	0.00	2.61	0.44	0.87
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	38.44	2.26	5.88	0.45	0.45	0.00	0.00	0.45	1.36	3.62
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	44.10	0.88	0.88	0.88	0.00	0.00	0.00	0.00	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	33.24	1.99	4.65	0.00	0.66	0.00	0.00	0.66	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	65.48	0.99	5.95	0.99	1.98	0.50	0.00	0.99	0.00	1.49
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	34.07	1.53	1.91	0.38	0.38	0.38	0.00	0.77	0.00	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	62.30	1.81	2.42	1.21	0.60	0.30	0.00	0.60	0.00	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	54.15	1.55	4.64	0.22	1.33	0.00	0.22	0.66	0.22	1.33
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	41.34	0.68	0.00	0.00	1.36	0.00	0.68	1.36	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	71.53	5.11	0.00	0.00	5.11	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	42.68	3.05	4.88	0.61	0.00	0.00	0.00	2.44	0.00	1.83
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	28.33	2.20	4.72	0.63	0.31	0.00	0.00	0.94	0.00	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	52.66	2.42	3.33	0.91	0.91	0.00	0.30	0.91	0.30	0.61
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	57.75	1.58	1.58	0.00	2.37	0.00	0.00	2.37	0.79	1.58
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	87.29	3.40	0.00	0.00	5.67	0.00	0.00	1.13	1.13	2.27
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	55.64	0.00	0.00	0.00	15.17	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	12.05	0.75	1.99	0.37	0.25	0.00	0.12	0.62	0.50	0.00
Myoblast, donor2	11322-117D8	29.92	0.19	1.53	0.58	1.15	0.38	0.00	1.34	0.58	0.38
Myoblast, donor3	11398-118D3	24.05	1.51	3.20	0.50	1.18	0.00	0.17	2.02	0.17	0.84
NK T cell leukemia cell line:KHYG-1	10777-110G3	33.71	0.00	1.17	0.73	0.29	0.00	0.00	0.00	0.15	0.29
Natural Killer Cells, donor1	11230-116C6	35.36	2.15	4.92	1.23	0.92	1.85	1.23	0.00	0.62	0.00
Natural Killer Cells, donor2	11311-117C6	16.89	2.41	3.62	0.60	0.60	0.60	0.90	0.00	0.90	0.90
Natural Killer Cells, donor3	11387-118C1	17.67	3.68	3.50	0.74	0.18	1.47	1.47	0.00	0.00	0.37
Neural stem cells, donor1	11275-116H6	97.27	5.44	16.70	1.45	10.53	0.36	0.00	1.09	0.73	7.26
Neural stem cells, donor2	11352-117H2	55.84	11.55	9.63	1.93	0.00	1.93	0.00	0.00	0.00	5.78
Neurons, donor1	11494-119E9	31.86	15.93	11.38	1.14	0.00	2.28	0.00	3.41	1.14	1.14
Neurons, donor2	11574-120E8	38.53	8.81	14.53	1.54	1.98	0.44	0.44	0.88	1.76	1.54
Neurons, donor3	11655-122E8	65.77	8.22	6.58	0.82	4.11	0.82	0.00	0.00	1.64	2.47
Neutrophils, donor1	11233-116C9	6.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	5.80	0.00	0.00	0.00	2.90	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	3.67	0.00	0.00	2.44	0.00	0.61	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	51.53	3.92	3.80	0.95	2.14	0.36	0.24	2.97	0.83	1.19
Nucleus Pulposus Cell, donor2	11409-118E5	31.58	0.65	1.63	0.65	0.98	0.00	0.33	1.95	0.33	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	13.24	1.00	2.41	0.20	0.00	0.00	0.20	0.40	0.60	0.20
Olfactory epithelial cells, donor1	11933-125I7	23.13	4.13	2.89	0.41	0.83	0.96	0.83	0.14	0.69	0.41
Olfactory epithelial cells, donor2	11934-125I8	23.74	3.62	3.91	0.29	1.01	0.58	0.58	1.01	0.14	0.29
Olfactory epithelial cells, donor3	11935-125I9	10.90	6.02	3.18	0.45	0.68	2.16	0.34	0.23	0.45	0.11
Olfactory epithelial cells, donor4	11936-126A1	18.70	5.84	4.97	0.97	0.58	0.39	0.68	0.10	0.68	0.29
Oligodendrocyte - precursors, donor1	11496-119F2	10.83	4.81	4.21	1.20	0.60	0.60	0.60	0.00	0.60	0.00
Osteoblast - differentiated, donor1	11276-116H7	20.21	3.62	0.21	0.64	1.28	1.91	0.21	0.64	0.21	0.43
Osteoblast - differentiated, donor2	11353-117H3	17.15	3.43	0.00	0.00	0.00	1.14	1.14	1.14	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	9.31	4.97	0.62	1.24	0.00	0.00	0.62	0.62	0.00	0.62
Osteoblast, donor1	11277-116H8	36.55	1.37	0.98	0.20	3.13	0.20	0.00	0.78	1.37	1.56
Osteoblast, donor2	11354-117H4	30.20	0.00	0.00	0.70	0.00	0.00	0.00	0.00	0.00	0.70
Osteoblast, donor3	11426-118G4	19.02	1.07	1.42	0.53	0.53	0.00	0.00	0.71	0.00	0.18
Pancreatic stromal cells, donor1	11249-116E7	9.27	2.02	1.94	0.59	0.51	0.17	0.25	0.25	0.42	0.00
Pericytes, donor1	11491-119E6	65.98	3.45	2.89	0.78	4.12	3.23	0.22	2.56	2.45	4.34
Pericytes, donor2	11571-120E5	83.08	2.94	3.17	0.45	1.81	2.04	0.91	1.58	2.04	5.89
Pericytes, donor3	11652-122E5	26.25	2.64	3.66	0.61	0.41	0.00	0.20	0.61	0.20	0.61
Perineurial Cells, donor1	11499-119F5	26.56	1.24	2.26	0.68	1.58	0.11	0.00	0.11	0.45	0.57
Perineurial Cells, donor2	11579-120F4	20.06	0.28	3.22	1.38	1.93	0.09	0.00	0.18	0.18	0.83
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	28.37	2.87	3.82	0.96	0.00	0.32	0.32	0.00	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	15.67	0.73	1.22	0.00	0.00	0.00	0.49	0.00	0.00	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	18.38	3.36	3.62	0.78	0.39	0.26	0.52	0.00	0.00	0.13
Placental Epithelial Cells, donor1	11278-116H9	2.87	3.59	4.54	1.67	0.24	2.39	0.96	0.00	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	4.44	6.65	2.22	0.00	1.11	2.22	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	11.98	3.34	3.53	3.14	0.59	0.79	0.39	0.00	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	25.32	9.81	6.33	0.95	0.63	2.85	0.00	1.58	0.95	0.95
Preadipocyte - breast, donor1	11467-119B9	32.64	8.63	5.06	2.06	2.06	1.13	0.38	1.69	0.75	0.75
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	45.82	7.44	4.31	1.83	4.31	0.91	0.65	0.91	1.17	0.52
Preadipocyte - breast, donor2	11328-117E5	29.49	7.43	6.98	2.48	2.48	1.80	0.23	0.90	0.68	0.23
Preadipocyte - omental, donor1	11468-119C1	33.78	8.21	4.69	0.96	2.13	2.77	0.53	1.49	0.85	0.96
Preadipocyte - omental, donor2	11329-117E6	27.06	5.24	4.80	1.31	4.36	1.31	0.00	0.44	0.87	0.44
Preadipocyte - omental, donor3	11403-118D8	32.80	6.73	9.17	0.72	1.00	0.86	0.29	0.86	0.43	0.29
Preadipocyte - perirenal, donor1	11469-119C2	9.84	1.97	4.92	1.97	0.00	0.00	0.00	0.00	0.98	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	27.95	0.00	0.31	0.00	0.92	0.00	0.00	0.00	0.61	0.61
Preadipocyte - subcutaneous, donor2	11356-117H6	14.70	0.35	1.42	0.53	1.24	0.00	0.00	0.00	0.53	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	15.67	0.68	2.21	0.34	0.51	0.00	0.00	0.51	0.17	0.17
Preadipocyte - visceral, donor1	11280-116I2	22.17	0.84	1.96	0.09	1.40	0.00	0.00	0.19	0.47	0.47
Preadipocyte - visceral, donor2	11357-117H7	15.19	0.00	1.38	0.92	0.00	0.00	0.00	0.46	0.00	0.46
Preadipocyte - visceral, donor3	11429-118G7	14.00	0.42	2.30	0.42	0.10	0.00	0.10	0.10	0.21	0.31
Prostate Epithelial Cells (polarized), donor1	11253-116F2	7.39	13.88	4.07	1.06	0.75	3.62	1.66	0.00	0.15	0.60
Prostate Epithelial Cells, donor2	11331-117E8	13.27	6.09	5.55	1.08	0.14	1.08	0.95	0.14	0.00	0.00
Prostate Epithelial Cells, donor3	11404-118D9	1.29	17.58	1.22	2.02	0.00	3.31	3.31	0.00	0.00	0.00
Prostate Stromal Cells, donor1	11254-116F3	11.39	1.14	1.37	0.34	0.91	0.00	0.00	0.00	0.23	0.23
Prostate Stromal Cells, donor2	11332-117E9	10.58	0.90	1.79	0.18	0.54	0.18	0.00	0.00	0.00	0.18
Prostate Stromal Cells, donor3	11405-118E1	9.07	1.56	2.29	0.21	0.10	0.21	0.00	0.00	0.00	0.10
Renal Cortical Epithelial Cells, donor1	11516-119H4	20.07	9.12	3.65	2.92	0.36	1.09	1.09	0.36	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	11.71	3.19	3.40	2.01	0.21	0.28	0.76	0.14	0.14	0.21
Renal Epithelial Cells, donor1	11517-119H5	13.19	3.55	4.06	3.04	0.00	0.00	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	26.32	7.11	2.85	0.71	2.13	0.71	0.00	0.71	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	31.02	3.39	3.39	2.01	1.27	0.11	0.53	0.21	0.11	0.64
Renal Glomerular Endothelial Cells, donor1	11514-119H2	19.74	0.68	1.36	2.04	0.00	0.00	0.68	1.36	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	14.29	2.02	1.89	0.67	0.00	0.00	0.13	1.35	0.67	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	19.54	1.78	1.11	0.89	0.89	0.00	0.22	0.44	0.22	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	20.63	2.66	3.33	0.00	2.00	0.00	0.00	0.67	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	33.01	1.54	2.86	0.44	0.44	0.00	0.00	0.00	0.22	1.32
Renal Mesangial Cells, donor2	11598-120H5	28.21	1.25	2.51	1.88	0.63	0.00	0.00	1.88	1.25	0.00
Renal Mesangial Cells, donor3	11679-122H5	18.59	1.66	3.33	1.39	0.83	0.00	0.28	0.28	0.55	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	8.86	10.74	4.56	2.68	0.00	0.27	1.34	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	6.75	12.65	4.22	3.80	0.00	0.00	0.42	0.42	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	14.27	3.47	5.01	1.54	0.39	0.00	0.39	0.58	0.19	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	16.85	3.63	5.96	1.56	0.78	3.11	2.07	0.52	0.78	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	29.28	5.68	9.38	1.42	2.27	0.57	0.85	3.41	0.28	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	28.82	1.03	3.09	0.00	4.12	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	48.17	12.04	3.76	1.51	0.50	4.27	1.76	3.76	0.00	1.51
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	17.37	11.76	4.28	3.74	0.80	3.07	0.53	0.00	0.94	0.13
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	55.39	31.27	8.93	0.00	0.00	0.89	0.00	2.68	0.89	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	90.81	23.67	6.05	1.10	3.85	0.55	1.65	3.30	0.00	1.10
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	59.75	22.04	6.96	0.58	2.32	0.58	1.16	2.32	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	33.55	10.40	5.20	0.13	1.30	0.13	0.52	0.91	0.26	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	28.10	7.55	5.06	0.30	1.19	0.20	0.20	0.30	0.10	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	38.48	11.93	6.02	0.33	1.34	0.33	0.45	0.56	0.22	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	23.57	7.07	3.97	0.25	1.12	0.62	0.25	0.62	1.49	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	27.85	9.56	7.23	0.23	0.58	0.58	0.93	0.70	0.58	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	44.84	12.94	6.01	0.46	3.93	0.69	1.39	0.23	0.23	1.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	24.51	8.76	3.56	0.41	0.82	0.55	0.27	0.82	1.23	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	27.83	8.62	5.75	0.45	1.51	0.30	0.00	0.76	0.91	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	26.16	14.16	5.02	0.36	1.61	0.18	0.18	0.36	0.18	1.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	25.10	6.89	4.73	0.43	0.43	0.29	0.14	1.15	1.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	30.80	6.98	5.15	0.54	1.61	0.21	0.43	0.75	0.21	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	41.60	11.95	9.51	0.66	2.21	0.44	0.22	0.89	0.44	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	27.72	11.47	4.21	0.57	0.57	0.00	0.19	0.38	0.00	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	28.04	8.94	7.45	0.84	1.58	0.37	0.65	0.47	0.09	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	45.10	15.03	6.39	0.75	1.32	0.56	0.56	1.32	0.00	1.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	26.81	9.16	6.77	0.66	0.93	0.27	0.93	1.99	1.06	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	28.23	8.57	5.74	0.19	0.78	0.29	0.58	1.07	0.10	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	32.65	10.12	6.87	0.95	0.95	0.38	0.38	1.34	0.00	0.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	24.78	8.01	4.49	0.32	0.53	0.11	0.21	1.60	0.64	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	31.39	9.25	4.48	0.00	2.24	0.00	0.28	1.96	0.56	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	36.40	10.60	5.81	0.51	1.37	0.68	0.51	2.05	0.51	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	32.27	8.93	6.38	0.55	0.91	0.18	0.36	1.28	1.28	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	29.43	6.99	5.52	0.37	0.98	0.12	0.61	1.47	0.25	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	31.97	10.07	6.72	0.40	2.01	0.13	0.67	1.48	0.81	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	27.13	7.31	4.48	0.71	0.24	0.00	0.00	1.42	0.94	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	28.97	8.53	4.96	0.60	2.38	0.40	0.20	1.59	0.40	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	40.46	10.52	7.25	0.70	1.87	0.70	0.47	2.34	0.23	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	25.09	4.77	5.60	0.00	0.62	0.00	0.00	2.28	0.41	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	41.81	9.51	5.97	0.22	2.65	0.66	0.22	2.65	0.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	28.20	8.36	7.94	1.04	1.88	0.21	0.21	2.09	0.00	0.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	26.51	5.52	4.85	0.13	0.81	0.27	0.00	1.35	0.94	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	29.46	9.54	6.47	0.00	1.02	0.34	0.51	2.21	0.17	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	30.08	10.60	6.36	0.39	0.77	0.19	0.39	0.77	0.58	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	23.21	4.30	3.78	0.00	1.55	0.00	0.00	1.55	0.86	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	23.73	8.50	6.72	0.27	2.06	0.00	0.55	1.10	0.27	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	29.88	10.18	7.55	0.66	1.64	0.33	0.49	0.82	0.49	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	25.91	7.33	7.16	0.00	1.36	0.34	0.51	1.19	0.17	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	26.78	6.66	8.43	0.89	2.07	0.30	0.15	0.59	0.44	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	28.25	10.40	6.66	0.80	1.07	0.27	0.00	1.87	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	32.63	13.83	8.71	0.41	1.11	0.28	0.14	1.52	0.69	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	28.81	8.57	8.81	0.71	1.43	0.24	0.24	0.95	0.24	1.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	46.96	22.37	10.28	0.81	2.42	1.01	0.60	1.61	0.20	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	25.43	11.77	5.65	0.47	0.47	0.19	0.19	1.41	1.51	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	42.97	17.82	8.38	0.35	2.45	1.40	0.70	3.84	0.70	1.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	36.87	20.25	9.37	0.91	1.21	0.30	0.60	7.56	0.30	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	28.76	14.07	4.77	0.49	1.35	0.49	0.00	1.35	1.59	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	63.46	28.96	12.52	0.73	6.70	2.04	2.04	5.68	0.44	3.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	52.32	22.51	6.08	0.00	3.65	0.61	1.22	3.04	1.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	28.93	12.96	4.82	0.90	0.30	0.30	0.90	1.51	0.30	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	43.43	21.04	7.69	0.45	3.17	1.81	1.81	1.58	1.13	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	51.22	22.77	9.88	1.20	4.19	0.90	1.20	2.40	0.30	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	42.98	18.54	6.26	0.94	1.77	0.71	0.59	3.78	0.35	1.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	42.69	21.77	6.83	1.07	1.71	1.28	1.92	2.13	0.43	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	51.68	26.44	9.01	1.80	2.40	0.60	1.80	1.80	0.60	0.60
Schwann Cells, donor1	11498-119F4	25.20	0.38	3.57	1.32	0.38	0.19	0.00	0.75	0.75	0.56
Schwann Cells, donor2	11578-120F3	10.21	3.40	0.00	0.00	3.40	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	34.61	1.10	2.19	0.22	0.66	0.00	0.00	0.88	1.53	0.22
Sebocyte, donor1	11220-116B5	9.31	11.50	4.93	2.19	1.10	9.31	2.19	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	4.14	10.57	4.14	2.76	0.00	6.89	0.92	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	17.93	4.53	3.92	1.86	0.41	3.30	1.65	0.00	0.00	0.00
Sertoli Cells, donor1	11255-116F4	19.88	3.31	3.31	0.00	3.31	0.00	0.00	0.00	0.00	1.66
Sertoli Cells, donor2	11333-117F1	19.77	11.30	2.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	32.46	3.08	1.94	0.79	1.14	0.00	0.00	0.53	0.26	0.62
Skeletal Muscle Cells, donor2	11358-117H8	13.01	6.51	1.45	1.45	0.72	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	29.26	0.00	0.84	0.00	1.67	0.00	0.00	0.00	0.84	0.84
Skeletal Muscle Cells, donor4	11451-119A2	20.58	0.16	1.10	0.63	0.79	0.00	0.00	0.63	0.00	1.26
Skeletal Muscle Cells, donor5	11455-119A6	17.69	0.74	1.64	1.49	0.59	0.00	0.15	0.00	0.89	0.59
Skeletal Muscle Cells, donor6	11459-119B1	21.24	0.77	2.00	0.62	0.62	0.00	0.00	0.46	0.15	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	28.86	0.50	2.27	0.63	2.27	0.00	0.00	0.50	0.50	0.88
Skeletal Muscle Satellite Cells, donor2	11321-117D7	16.84	0.43	1.57	0.71	0.71	0.00	0.00	0.29	0.43	0.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	17.56	0.69	2.08	0.30	0.20	0.00	0.00	0.30	0.20	1.09
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	47.69	1.35	1.94	0.59	2.61	0.25	0.00	0.00	0.67	1.26
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	10.86	1.45	0.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	40.59	0.83	2.20	0.28	1.93	0.00	0.00	1.10	1.93	0.96
Skin - palm, donor1	10286-104F7	16.12	29.55	2.69	2.69	0.00	0.00	2.69	2.69	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	7.50	6.20	4.32	2.45	0.00	1.30	1.01	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	76.88	25.35	4.09	4.09	0.00	4.09	2.45	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	3.89	5.45	4.02	5.06	0.00	1.04	1.04	0.00	0.26	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	4.73	14.18	1.81	0.97	0.00	2.92	1.95	0.00	0.00	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	4.64	10.27	5.91	2.95	0.00	1.55	1.13	0.00	0.14	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	15.22	20.51	8.88	10.15	0.63	5.07	3.38	0.21	0.00	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	1.12	27.06	2.40	2.10	0.00	2.92	2.02	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	9.26	0.93	0.62	0.00	0.00	0.00	0.31	0.00	0.31	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	20.23	0.67	0.44	0.22	1.11	0.00	0.00	0.00	1.33	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	14.70	0.00	2.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	19.67	0.66	1.99	0.00	0.88	0.00	0.00	0.00	0.44	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	26.38	0.39	1.58	0.79	2.76	0.00	0.00	0.39	0.79	0.79
Smooth Muscle Cells - Aortic, donor3	11432-118H1	19.31	1.55	2.32	0.77	0.77	0.00	0.00	0.00	0.00	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	23.02	1.00	1.00	1.00	2.00	0.00	0.00	1.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	15.30	0.27	0.93	0.13	0.40	0.00	0.13	0.40	0.27	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	23.72	1.55	2.88	0.89	1.33	0.00	0.00	1.11	0.44	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	22.02	1.02	2.94	0.77	0.64	0.26	0.00	0.51	0.26	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	20.51	2.28	3.26	0.00	0.98	0.33	0.00	0.65	0.33	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	19.20	0.59	3.25	0.30	0.59	0.30	0.00	1.48	0.59	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	14.52	1.57	2.70	0.85	0.71	0.14	0.14	0.43	0.28	0.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	12.04	1.14	2.11	0.00	0.33	0.00	0.00	0.33	0.00	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	14.92	6.39	2.13	0.61	0.61	0.00	0.00	0.30	0.61	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	25.26	1.01	2.27	1.01	1.52	0.00	0.00	0.25	0.00	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	18.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	20.98	0.00	0.95	0.00	1.43	0.00	0.00	0.00	0.48	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	16.52	1.47	2.06	0.44	0.74	0.00	0.15	0.44	0.00	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	18.73	1.08	3.01	0.43	1.29	0.00	0.00	0.65	0.22	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	16.16	0.52	2.62	0.31	0.63	0.10	0.21	0.21	0.00	0.21
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	23.20	0.62	2.17	0.46	0.77	0.00	0.00	0.93	0.15	0.46
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	15.09	0.00	2.16	0.00	1.08	0.00	0.00	0.00	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	13.45	0.00	3.59	1.20	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	15.36	0.68	3.07	0.68	1.02	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	23.01	0.31	2.51	0.63	1.73	0.08	0.00	0.31	0.08	0.63
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	28.18	2.31	2.72	0.50	0.70	0.30	0.10	1.31	0.10	1.01
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	30.95	0.91	4.32	0.23	2.28	0.00	0.00	0.00	0.23	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	18.11	0.00	0.60	1.21	0.60	0.00	0.00	0.00	0.00	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	14.84	0.53	0.53	0.53	0.79	0.00	0.00	0.26	0.00	0.79
Smooth Muscle Cells - Prostate, donor1	11257-116F6	10.65	1.46	2.40	0.27	0.27	0.00	0.13	0.00	0.27	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	22.54	1.25	1.38	0.13	0.88	0.00	0.00	0.38	0.88	0.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	25.11	3.30	3.30	0.25	2.03	0.51	0.51	1.78	0.51	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	18.39	1.21	1.51	0.15	1.51	0.00	0.00	0.45	0.60	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	18.75	1.50	3.75	0.75	0.75	0.00	0.00	0.00	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	15.51	1.29	3.88	5.17	2.58	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	36.28	0.47	0.93	0.47	1.40	0.00	0.00	0.47	1.40	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	18.68	0.00	2.02	0.00	0.00	0.50	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	20.68	1.25	2.82	1.25	0.63	0.00	0.31	0.00	0.63	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	15.04	0.59	4.72	0.59	0.00	0.00	0.00	0.00	0.00	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	10.25	0.17	1.67	0.67	0.50	0.08	0.00	0.58	0.25	0.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	8.88	1.87	2.80	0.93	0.47	0.47	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	13.53	0.86	1.44	0.29	0.72	0.14	0.14	0.43	0.72	0.29
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	23.97	0.76	1.27	0.25	1.02	0.00	0.25	1.02	1.27	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	23.32	0.00	0.75	0.38	0.94	0.00	0.00	0.38	0.38	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	19.70	0.42	1.68	0.14	0.56	0.00	0.00	0.00	0.28	0.56
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	21.70	0.50	1.09	0.34	1.26	0.00	0.08	0.34	0.42	0.42
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	10.48	0.00	0.95	0.00	0.95	0.00	0.00	0.48	0.48	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	10.03	0.49	1.96	0.49	0.73	0.00	0.00	0.00	0.49	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	20.77	0.66	2.43	0.44	0.22	0.22	0.00	0.22	0.44	0.66
Smooth Muscle Cells - Uterine, donor3	11466-119B8	12.00	0.59	0.88	0.00	0.59	0.00	0.00	0.29	0.00	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	17.69	1.55	1.17	0.78	1.36	0.00	0.00	0.19	0.39	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	14.28	1.32	1.59	0.26	0.26	0.53	0.00	0.53	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	29.76	0.37	1.49	0.00	0.37	0.37	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	13.65	1.44	2.87	0.00	0.36	1.44	0.36	0.72	0.00	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	11.64	0.85	0.57	0.57	0.00	0.00	0.00	0.57	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	17.72	0.00	0.79	0.39	0.79	0.00	0.00	0.00	0.39	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	16.25	2.03	2.54	0.00	0.25	0.00	0.25	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	14.77	2.00	3.19	0.40	0.40	0.00	0.00	0.00	0.00	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	19.65	2.09	1.67	0.42	1.25	0.00	0.00	1.67	0.42	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	28.88	5.04	3.21	0.46	0.46	1.83	0.92	0.00	0.00	0.00
Synoviocyte, donor1	11291-117A4	41.91	9.76	3.53	1.01	2.19	1.68	0.50	2.86	0.84	2.86
Synoviocyte, donor2	11368-117I9	22.13	3.52	2.85	0.67	1.51	1.01	0.34	0.17	0.34	0.67
Synoviocyte, donor3	11440-118H9	18.99	3.80	2.01	0.45	0.22	0.45	0.00	0.67	0.67	0.67
Trabecular Meshwork Cells, donor1	11532-120A2	16.08	2.86	3.22	0.36	0.36	0.00	0.00	0.00	0.00	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	11.89	1.98	1.98	1.98	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	13.89	0.46	1.16	1.16	0.69	0.23	0.00	0.00	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	3.66	8.89	3.58	2.87	0.22	2.37	1.00	0.00	0.07	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	8.89	4.25	1.93	1.55	0.00	1.16	1.16	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	1.15	5.73	2.29	1.72	0.57	0.00	0.57	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	17.72	12.06	3.32	2.46	1.23	2.95	1.35	0.12	0.49	0.25
Urethra, donor2	10319-105A4	23.38	25.18	7.19	5.40	0.00	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	10.10	3.45	6.11	2.92	0.00	1.06	0.53	0.00	0.27	0.00
Urothelial Cells, donor2	11600-120H7	5.61	6.81	1.60	4.41	0.80	1.60	0.40	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	2.98	6.42	3.21	4.13	0.00	2.29	1.38	0.00	0.23	0.00
Urothelial cells, donor0	11216-116B1	5.13	3.57	4.68	5.57	0.00	2.45	1.56	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	19.58	1.78	6.23	2.67	0.00	0.00	0.00	0.00	0.89	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	25.73	2.86	2.86	7.15	0.00	0.00	0.00	0.00	0.00	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	23.96	0.00	7.53	0.68	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	31.68	1.03	3.10	2.75	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	31.96	0.58	1.16	1.74	0.00	0.00	0.58	0.00	1.16	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	21.87	1.04	1.04	0.00	0.00	0.00	0.00	0.00	2.08	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	19.27	1.84	3.67	1.84	0.92	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	19.17	0.91	3.65	0.00	0.91	0.00	0.91	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	28.25	10.98	8.64	1.85	1.85	1.97	0.86	0.00	0.49	0.49
Wilms' tumor cell line:HFWT	10597-108E3	6.16	69.52	6.16	2.64	0.00	2.64	0.88	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	1.68	13.69	3.63	3.07	0.00	1.12	1.40	0.56	0.00	0.00
achilles tendon, donor2	10292-104G4	31.00	4.13	0.00	0.00	4.13	0.00	0.00	2.07	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	38.75	0.00	0.00	0.51	0.25	0.00	0.00	0.00	0.00	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	55.49	6.73	3.02	1.16	1.39	0.46	0.46	0.00	0.46	0.46
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	41.19	0.00	0.00	0.00	0.95	0.00	0.00	0.00	0.24	0.47
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	48.44	7.07	1.90	1.09	0.00	0.54	0.82	0.00	1.36	0.82
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	99.78	3.94	1.12	0.56	0.56	0.00	0.00	0.00	2.25	1.41
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	37.22	1.06	1.48	0.42	0.85	0.00	0.00	0.00	0.21	0.42
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	42.19	8.17	1.63	0.00	1.36	0.00	0.27	0.00	0.82	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	55.52	3.08	2.64	1.32	1.32	0.88	0.00	0.00	0.88	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	65.75	0.00	0.00	0.00	0.41	0.00	0.00	0.00	0.00	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	122.70	0.00	0.00	0.00	1.94	0.00	0.00	0.00	0.39	2.72
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	21.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.55	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	62.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	67.86	0.00	0.23	0.00	1.16	0.00	0.00	0.00	1.39	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	65.24	3.37	2.85	2.33	0.52	0.00	0.00	0.00	1.29	0.78
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	48.22	0.29	0.00	0.00	1.46	0.00	0.00	0.00	0.58	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	12.08	0.46	0.00	0.46	0.00	0.00	0.00	0.00	0.46	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	102.40	0.00	0.00	0.00	1.65	0.00	0.00	0.00	0.41	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	13.20	1.84	2.46	0.31	1.23	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	30.30	2.13	2.99	0.00	1.71	0.00	0.00	0.00	0.00	1.28
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	19.71	0.91	1.21	0.91	1.82	0.00	0.00	0.00	0.91	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	30.57	2.65	3.37	0.24	1.68	0.24	0.00	0.00	0.24	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	31.63	2.45	0.00	0.00	0.45	0.00	0.45	0.00	0.45	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	25.02	0.00	0.00	0.00	0.33	0.00	0.00	0.00	0.00	0.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	22.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.86	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	35.41	0.00	0.75	0.38	0.00	0.00	0.00	0.00	0.38	0.75
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	46.23	0.00	0.00	0.00	0.44	0.00	0.00	0.00	0.00	1.74
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	48.74	0.00	3.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	1.65	37.44	3.30	0.00	0.00	2.35	1.41	0.00	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	33.04	7.91	2.64	2.02	2.17	0.62	0.31	0.31	0.62	0.47
adipose, donor1	10184-103D4	102.62	4.10	1.76	4.10	19.35	0.00	0.00	0.00	1.17	2.93
adipose, donor2	10185-103D5	49.47	3.65	6.89	1.22	6.89	0.00	0.41	0.00	2.43	2.84
adipose, donor3	10186-103D6	57.18	5.99	10.89	1.36	5.17	0.00	0.00	0.00	1.09	1.91
adipose, donor4	10187-103D7	39.00	2.60	1.73	3.47	3.47	0.87	0.00	0.00	0.87	1.73
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	14.52	10.26	2.84	1.10	0.79	0.47	0.47	0.00	0.00	0.00
adrenal gland, adult, pool1	10081-102A9	54.57	7.28	0.00	0.00	3.64	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	37.75	36.95	4.00	5.34	0.53	3.74	5.74	0.00	0.80	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	51.09	2.14	1.43	1.43	2.50	0.00	0.00	3.22	0.00	0.71
amniotic membrane cells, donor1	12235-129G3	0.46	11.36	4.17	6.96	0.00	5.80	3.71	0.00	0.00	0.00
amniotic membrane cells, donor2	12236-129G4	4.06	7.10	5.41	3.72	0.00	1.69	1.69	0.00	0.34	0.00
amniotic membrane cells, donor3	12237-129G5	0.00	16.20	1.77	6.19	0.00	4.12	3.54	0.00	0.00	0.00
amygdala - adult, donor10196	10167-103B5	16.60	9.49	11.86	0.00	2.37	0.00	0.00	3.56	0.00	1.19
amygdala, adult, donor10252	10151-102I7	50.69	20.68	10.54	0.41	4.26	0.61	0.20	4.06	0.20	0.61
amygdala, newborn, donor10223	10360-105E9	38.41	15.49	5.49	0.32	1.94	1.29	0.65	0.65	0.32	1.61
anaplastic carcinoma cell line:8305C	10428-106D5	85.31	1.78	5.22	0.76	4.46	0.51	0.00	2.55	2.04	3.44
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	52.29	1.10	4.19	0.22	0.44	0.00	0.22	0.00	0.22	0.66
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	28.39	16.37	11.02	1.00	2.34	1.34	1.34	0.00	0.00	0.67
aorta, adult, pool1	10052-101G7	52.17	22.16	15.49	3.14	1.77	1.77	1.37	2.16	0.39	0.59
appendix, adult	10189-103D9	43.08	11.64	6.99	3.49	0.39	1.55	0.00	1.16	1.16	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	14.45	7.91	5.16	0.34	0.00	0.69	0.69	0.00	0.00	0.34
artery, adult	10190-103E1	19.02	5.43	5.43	1.36	0.00	0.00	0.00	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	22.31	4.93	5.36	2.46	1.45	0.72	0.29	2.03	0.87	0.43
b cell line:RPMI1788	10427-106D4	24.54	0.00	0.30	0.30	0.30	0.00	0.00	0.00	0.00	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	13.32	5.83	3.33	0.83	0.55	0.28	0.00	0.55	0.00	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	4.96	8.24	1.69	1.49	0.20	0.50	0.69	0.60	0.30	0.20
bile duct carcinoma cell line:TFK-1	10496-107C1	2.01	46.53	2.18	1.51	0.00	2.68	3.01	0.00	0.00	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	20.69	1.12	0.00	0.00	0.00	0.00	0.00	0.00	0.56	0.00
bladder, adult, pool1	10011-101C2	29.77	8.26	5.87	3.48	1.63	0.87	0.98	0.43	0.33	0.43
blood, adult, pool1	10053-101G8	13.29	0.00	2.21	4.43	0.00	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	9.42	1.71	4.28	1.71	0.86	0.00	0.86	1.71	0.00	0.00
bone marrow, adult	10192-103E3	70.18	2.70	4.05	0.67	3.37	0.00	0.00	0.67	0.67	2.02
brain, adult, donor1	10084-102B3	27.68	4.10	11.28	0.00	6.15	0.00	0.00	2.05	0.00	0.00
brain, adult, pool1	10012-101C3	14.92	9.24	8.35	0.45	2.23	0.22	0.11	1.34	0.33	0.22
brain, fetal, pool1	10085-102B4	61.44	24.04	16.03	0.00	5.34	2.67	2.67	2.67	0.00	2.67
breast carcinoma cell line:MCF7	10482-107A5	5.95	57.15	6.61	1.65	0.33	9.58	2.64	0.00	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	6.99	18.22	1.12	3.12	0.12	2.25	1.50	0.00	0.12	0.00
breast, adult, donor1	10080-102A8	38.51	8.21	0.63	5.68	1.26	2.53	0.63	0.00	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	10.42	10.67	2.16	2.79	0.00	1.40	1.65	0.13	0.13	0.13
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	21.65	19.17	6.49	1.55	0.93	0.31	0.62	0.00	0.31	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	41.90	0.00	0.00	0.00	0.69	0.00	0.00	1.15	0.92	0.46
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	0.97	11.14	1.21	1.21	0.00	0.97	2.18	0.00	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	24.45	14.11	9.40	0.94	1.41	0.94	1.41	2.35	1.41	0.00
carcinoid cell line:NCI-H727	10735-110B6	2.73	9.95	1.31	1.20	0.22	0.55	0.55	0.00	0.00	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	18.70	4.75	3.80	0.32	1.27	0.00	0.32	0.00	0.00	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	35.93	8.52	7.45	0.80	0.27	0.27	0.53	11.18	0.00	0.00
caudate nucleus - adult, donor10196	10177-103C6	24.18	5.76	4.61	0.00	3.45	0.00	0.00	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	36.64	25.27	15.73	0.00	2.84	1.51	1.84	0.84	0.33	0.33
caudate nucleus, adult, donor10258	10379-105H1	19.87	9.17	13.75	0.76	0.00	0.00	0.00	0.00	0.00	1.53
caudate nucleus, newborn, donor10223	10354-105E3	48.34	4.39	10.25	1.10	2.56	2.93	0.37	0.00	0.00	0.73
cerebellum - adult, donor10196	10173-103C2	11.65	14.57	11.65	0.00	2.91	0.00	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	28.61	36.30	11.74	0.43	3.42	1.49	2.14	0.21	1.07	0.43
cerebellum, adult, pool1	10083-102B2	13.11	13.11	8.62	0.00	0.00	1.03	0.69	0.34	0.69	0.00
cerebellum, newborn, donor10223	10357-105E6	51.48	39.85	15.78	0.83	6.64	6.64	0.83	1.66	0.83	0.83
cerebral meninges, adult	10188-103D8	20.93	14.62	13.87	0.76	2.02	0.76	0.00	6.56	0.76	1.51
cerebrospinal fluid, donor2	10294-104G6	16.81	1.46	3.65	0.73	2.19	0.00	0.00	0.00	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	10.50	18.98	2.44	0.86	0.14	1.87	3.45	0.00	0.58	0.00
cervical cancer cell line:ME-180	10553-107I4	0.00	27.01	2.32	2.82	0.00	6.79	3.65	0.00	0.17	0.00
cervix, adult, pool1	10013-101C4	50.82	17.11	10.60	4.83	3.57	2.10	0.73	0.10	1.26	0.94
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	41.52	1.81	5.02	0.14	3.07	0.00	0.00	4.46	0.56	1.81
chondrosarcoma cell line:SW 1353	10700-109G7	6.53	1.31	1.31	1.31	0.00	0.00	0.00	1.31	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	0.00	16.40	5.22	9.07	0.00	4.23	2.61	0.00	0.12	0.00
choriocarcinoma cell line:SCH	10785-110H2	0.00	30.56	7.89	7.64	0.00	4.19	2.71	0.00	0.00	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	0.00	34.87	4.98	6.64	0.00	1.90	0.47	0.00	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	2.85	17.38	3.13	6.84	0.00	5.70	3.99	0.00	0.28	0.00
chorionic membrane cells, donor2	12239-129G7	9.05	5.37	3.28	1.99	0.60	1.69	0.70	0.10	0.40	0.00
chorionic membrane cells, donor3	12240-129G8	1.10	24.18	7.14	10.99	0.00	6.04	4.40	0.00	0.55	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	43.42	4.04	0.00	1.01	1.01	0.00	2.02	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	38.42	0.00	0.00	0.00	1.73	0.00	0.00	0.00	0.19	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	26.40	4.22	1.48	0.63	0.00	0.00	0.00	0.00	0.21	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	13.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.51	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	16.93	0.00	0.00	0.24	0.24	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	14.86	0.00	0.20	0.00	0.20	0.00	0.00	0.00	0.00	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	24.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.18	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	46.65	0.00	0.00	0.00	1.56	0.00	0.00	0.00	0.78	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	9.60	13.26	5.26	2.06	0.23	0.23	0.23	0.00	0.00	0.00
clear cell carcinoma cell line:TEN	10636-108I6	6.42	11.45	3.30	1.74	0.35	0.35	0.52	0.00	0.00	0.00
colon carcinoma cell line:CACO-2	10513-107D9	6.96	11.35	4.58	2.93	0.00	2.56	0.55	0.00	0.00	0.18
colon carcinoma cell line:COLO-320	10420-106C6	58.91	10.26	5.70	4.18	2.66	2.28	1.52	0.00	0.00	2.28
colon, adult, donor1	10082-102B1	33.32	21.42	10.71	2.38	2.38	2.38	0.00	0.00	1.19	1.19
colon, adult, pool1	10014-101C5	19.15	19.27	5.52	2.94	1.18	2.00	1.65	0.35	0.59	0.59
colon, fetal, donor1	10070-101I7	45.73	12.36	3.71	1.24	0.00	0.00	0.00	0.00	1.24	0.62
common myeloid progenitor CMP, donor1	12130-128D6	50.42	4.58	0.00	13.75	0.00	0.00	4.58	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	11.90	0.42	0.42	0.42	0.00	0.00	0.85	0.00	0.42	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	14.49	0.30	0.15	0.15	0.75	0.00	0.00	0.00	0.45	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	15.93	0.71	0.42	0.28	0.85	0.00	0.00	0.00	0.42	0.00
corpus callosum, adult, pool1	10042-101F6	58.16	2.43	8.18	0.33	5.20	0.44	0.00	1.44	1.88	1.66
cruciate ligament, donor2	10295-104G7	70.51	4.86	4.86	2.43	4.05	0.81	0.00	8.10	2.43	1.62
diaphragm, fetal, donor1	10069-101I6	65.01	2.41	4.01	3.21	0.80	0.00	0.00	0.00	0.80	0.80
diencephalon, adult	10193-103E4	19.68	1.92	5.52	0.00	1.68	0.00	0.24	1.20	0.24	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	51.20	3.90	3.44	2.53	1.61	0.23	0.92	0.00	0.69	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	3.59	31.03	2.31	2.31	0.00	4.10	1.80	0.00	0.00	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	10.35	4.09	1.20	0.72	0.24	0.24	0.00	0.72	0.48	0.24
ductus deferens, adult	10196-103E7	22.43	16.45	7.48	0.50	0.50	3.49	1.50	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	50.41	18.72	5.76	1.44	1.44	2.88	2.88	0.00	1.44	2.88
duodenum, fetal, donor1, tech_rep2	10071-101I8	69.15	19.13	12.51	3.68	4.41	1.47	0.74	0.00	1.47	0.00
dura mater, adult, donor1	10041-101F5	41.05	7.27	9.08	0.58	2.15	0.91	0.17	1.32	1.16	0.66
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	6.88	1.78	1.55	1.33	0.67	0.44	0.00	0.00	0.22	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	13.47	7.74	1.58	1.00	0.57	0.72	0.72	0.00	0.14	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	35.76	14.80	3.70	0.00	0.00	0.62	0.00	4.32	0.62	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	31.18	4.24	3.63	1.21	1.51	0.00	0.00	0.91	0.30	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	33.65	8.03	2.47	0.93	0.93	0.00	1.23	4.32	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	19.70	13.13	1.31	2.63	0.00	0.00	1.31	2.63	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	33.52	35.87	8.72	1.68	0.67	2.35	5.03	0.67	1.34	0.67
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	57.27	6.16	3.26	0.72	1.45	0.18	0.18	0.00	0.18	0.54
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	17.69	13.99	3.86	2.89	0.48	8.04	3.22	0.16	0.00	0.16
epidermoid carcinoma cell line:A431	10426-106D3	0.56	10.45	2.67	2.78	0.00	1.67	1.22	0.00	0.00	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	7.48	6.71	2.97	3.52	0.11	1.54	1.76	0.00	0.00	0.00
epididymis, adult	10197-103E8	29.72	11.30	14.23	4.19	2.30	1.26	0.63	0.00	2.09	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	27.50	2.84	4.79	0.71	0.53	0.18	0.00	1.95	0.35	1.60
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	12.98	3.93	2.36	1.57	0.00	0.00	0.00	0.00	0.39	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	13.24	10.22	0.92	0.13	1.05	2.10	2.62	0.00	0.26	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	11.81	10.63	1.18	1.48	0.89	1.77	2.76	0.00	0.59	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	12.55	10.87	1.34	1.01	0.67	1.34	2.02	0.00	0.22	0.00
esophagus, adult, pool1	10015-101C6	12.85	16.67	4.88	4.67	0.85	3.82	2.23	0.11	0.21	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	27.55	45.34	3.01	1.25	1.50	2.76	2.25	0.00	0.38	0.75
eye - muscle inferior rectus, donor1	10272-104E2	50.71	21.73	12.07	2.41	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	25.25	4.21	4.21	2.10	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	22.32	8.93	2.98	1.49	1.49	0.00	0.00	0.00	1.49	0.00
eye - muscle superior, donor2	10297-104G9	38.98	2.29	2.29	1.15	1.15	0.00	0.00	0.00	1.15	0.00
eye - vitreous humor, donor1	10268-104D7	17.49	4.37	5.83	0.00	0.00	0.00	0.00	0.00	0.00	1.46
eye, fetal, donor1	10054-101G9	45.00	14.75	6.61	2.03	1.78	1.53	0.76	0.00	0.51	0.76
fibrosarcoma cell line:HT-1080	10758-110E2	40.90	0.38	1.03	0.13	1.03	0.00	0.00	1.41	0.51	0.64
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	28.02	0.47	0.47	0.00	0.95	0.00	0.00	0.71	0.47	0.47
frontal lobe, adult, pool1	10040-101F4	21.67	13.98	15.11	0.38	2.16	0.84	0.19	3.00	0.47	0.75
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	14.11	24.02	5.70	7.21	0.30	5.10	2.40	0.00	0.30	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	11.16	5.12	3.75	1.10	0.46	0.37	0.64	0.37	0.09	0.09
gall bladder, adult	10198-103E9	29.70	14.97	8.21	1.93	1.21	0.97	1.69	0.48	0.48	0.24
gamma delta positive T cells, donor1	11937-126A2	48.32	1.07	2.15	1.61	0.54	1.07	1.07	0.00	1.07	0.00
gamma delta positive T cells, donor2	11938-126A3	44.45	0.75	2.61	1.49	0.75	0.37	0.37	0.00	1.87	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	17.95	5.07	5.49	0.63	0.63	0.84	1.27	2.32	0.00	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	6.38	51.84	0.77	0.39	0.00	2.90	2.90	0.00	0.00	0.00
gastric cancer cell line:AZ521	10549-107H9	36.73	28.04	4.26	1.15	3.61	2.62	2.13	0.00	0.98	0.98
gastric cancer cell line:GSS	10560-108A2	27.46	12.81	4.58	3.66	1.83	0.00	1.83	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	36.55	0.00	0.00	0.00	2.06	0.00	0.00	0.00	0.00	0.23
giant cell carcinoma cell line:LU65	10487-107B1	4.47	9.75	0.11	0.00	0.00	1.84	2.18	0.11	0.00	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	29.11	0.56	3.92	0.56	1.54	0.00	0.14	2.80	0.28	0.42
glassy cell carcinoma cell line:HOKUG	10688-109F4	3.99	24.94	4.74	3.99	0.25	2.74	2.49	0.25	0.50	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	34.73	0.84	3.38	0.11	1.48	0.11	0.00	2.01	0.32	1.16
glioblastoma cell line:A172, tech_rep2	10444-106F3	34.55	0.28	3.23	0.56	2.11	0.00	0.00	2.11	0.00	1.40
glioblastoma cell line:T98G	10485-107A8	22.07	1.21	2.32	1.10	1.88	0.33	0.00	1.21	0.77	0.33
glioma cell line:GI-1	10413-106B8	33.39	0.88	2.05	0.00	2.64	0.29	0.29	1.46	0.29	1.17
globus pallidus - adult, donor10196	10175-103C4	40.09	4.37	6.56	0.00	0.73	0.00	0.73	0.73	1.46	0.00
globus pallidus, adult, donor10252	10161-103A8	53.46	6.59	5.37	0.98	3.42	0.00	0.24	1.71	0.73	1.22
globus pallidus, adult, donor10258	10367-105F7	30.12	2.74	6.85	0.00	1.37	0.00	0.00	1.37	0.00	1.37
globus pallidus, newborn, donor10223	10364-105F4	41.03	2.13	5.33	1.07	2.66	0.53	0.00	0.53	0.53	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	53.84	9.79	2.45	4.89	0.00	2.45	0.00	0.00	0.00	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	54.64	0.00	10.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	41.81	5.23	0.00	5.23	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	31.36	3.84	1.92	0.64	1.28	0.00	0.00	0.00	0.00	1.60
hIPS +CCl2, biol_rep1	14383-156B9	13.31	3.21	1.84	2.75	0.00	0.00	0.46	0.00	0.46	0.00
hIPS +CCl2, biol_rep2	14384-156C1	17.38	2.29	0.91	1.37	0.00	0.00	0.00	0.00	0.00	0.91
hIPS +CCl2, biol_rep3	14385-156C2	13.53	3.86	0.64	1.93	0.00	0.64	0.64	0.00	0.00	0.00
hIPS, biol_rep1	14380-156B6	47.43	4.31	0.00	1.44	0.00	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	14.40	2.74	0.00	1.37	0.00	0.69	0.69	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	20.97	4.41	5.52	2.21	0.00	0.00	0.00	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	44.54	0.29	0.00	0.57	0.29	0.00	0.00	0.00	1.15	0.57
heart - mitral valve, adult	10205-103F7	49.33	3.89	7.47	2.69	2.39	0.00	0.00	0.00	1.79	0.00
heart - pulmonic valve, adult	10206-103F8	36.61	8.11	9.94	1.57	0.78	0.78	0.78	1.05	0.52	0.52
heart - tricuspid valve, adult	10207-103F9	47.46	14.99	5.83	3.33	3.33	3.33	0.83	0.00	5.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	15.92	14.49	5.10	1.43	0.41	2.24	1.02	0.41	0.00	0.00
heart, adult, diseased, donor1	10051-101G6	33.21	1.28	3.41	0.43	1.70	0.00	0.00	0.00	0.00	0.43
heart, adult, pool1	10016-101C7	9.43	2.99	4.60	2.76	0.92	0.69	0.46	0.23	0.69	0.00
heart, fetal, pool1	10046-101G1	56.06	6.67	5.85	2.46	4.00	0.41	0.31	0.00	0.21	1.44
hepatic mesenchymal tumor cell line:LI90	10778-110G4	24.99	1.85	4.94	1.23	1.23	0.00	0.00	0.62	0.00	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	33.30	48.76	2.38	5.95	2.38	2.38	0.00	0.00	1.19	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	25.64	5.19	4.75	0.66	1.33	0.00	0.44	0.00	0.22	0.88
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	27.67	5.83	4.25	0.49	0.97	0.12	0.12	0.00	0.36	0.73
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	29.71	6.47	3.03	0.91	1.62	0.20	0.00	0.00	0.71	0.91
hepatoma cell line:Li-7	10484-107A7	11.46	11.79	2.11	0.33	0.89	1.33	1.00	0.00	0.11	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	48.74	0.00	0.00	0.00	0.80	0.00	0.00	0.00	0.30	0.70
hippocampus - adult, donor10196	10169-103B7	31.23	6.62	6.62	0.00	1.89	0.95	1.89	3.79	1.89	0.00
hippocampus, adult, donor10252	10153-102I9	57.35	11.43	11.63	0.82	4.69	0.61	0.61	2.45	1.22	1.22
hippocampus, adult, donor10258	10374-105G5	14.94	14.94	7.97	0.00	0.00	0.00	0.00	3.98	0.00	0.50
hippocampus, newborn, donor10223	10363-105F3	25.73	10.93	15.51	0.70	0.70	0.70	1.06	0.00	0.00	0.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	50.66	3.66	0.61	6.71	2.44	1.22	3.05	0.00	0.61	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	28.67	2.36	0.59	1.96	1.57	1.18	1.37	0.00	0.20	1.57
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	39.10	2.29	1.02	3.81	0.00	1.27	0.25	0.00	0.25	1.02
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	45.11	3.95	5.07	2.26	6.20	0.00	0.00	0.00	0.56	1.69
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	46.99	2.84	10.33	4.91	8.78	0.26	0.52	0.00	0.77	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	37.20	1.14	8.73	4.18	6.45	0.00	0.38	0.00	1.90	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	66.86	4.09	9.34	1.75	11.39	0.29	0.29	0.00	0.29	4.96
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	62.47	4.74	7.32	1.51	8.83	1.08	0.43	0.00	0.86	4.09
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	57.14	5.42	5.84	1.67	7.09	1.25	0.42	0.00	0.83	3.75
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	42.62	2.13	5.92	0.71	4.74	0.95	0.47	0.00	0.95	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	57.38	5.14	6.11	1.61	6.27	0.64	0.16	0.00	1.13	2.25
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	43.76	5.39	8.08	2.02	4.71	1.35	0.00	0.00	1.35	1.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	21.75	3.60	0.47	5.01	1.56	1.25	0.94	0.00	0.47	0.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	34.88	2.95	0.49	3.93	0.49	1.97	1.97	0.00	0.98	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	45.38	2.62	0.87	1.75	1.75	2.62	2.62	0.00	0.00	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	43.72	4.77	10.50	6.87	5.35	0.19	0.38	0.00	1.53	2.48
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	44.04	6.11	10.47	5.67	3.49	0.87	1.31	0.00	0.44	1.74
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	70.47	3.50	4.50	2.00	7.00	0.50	0.00	0.00	1.50	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	43.33	3.58	9.04	1.88	6.03	0.00	0.00	0.00	2.07	1.70
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	60.93	4.55	9.09	1.36	5.46	0.45	0.00	0.00	3.18	1.36
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	51.06	5.33	9.08	2.19	9.40	0.31	0.00	0.00	0.63	3.45
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	61.07	5.88	8.82	1.96	5.72	0.65	0.49	0.00	0.98	1.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	57.48	6.68	9.87	2.32	4.06	0.29	0.00	0.00	1.74	2.03
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	71.44	4.78	8.07	1.79	7.77	0.90	0.00	0.00	1.79	1.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	24.20	2.40	0.92	2.96	2.22	0.74	0.55	0.00	0.92	0.74
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	24.25	2.00	0.86	3.42	2.28	0.29	0.57	0.00	1.14	0.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	35.11	4.49	0.41	4.08	1.22	0.41	1.22	0.00	0.00	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	44.71	5.28	8.45	2.46	3.52	0.00	0.35	0.00	1.06	1.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	29.46	6.02	5.38	6.02	1.58	0.63	0.95	0.00	1.27	1.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	28.75	4.84	10.29	4.54	3.63	0.30	0.30	0.00	2.12	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	54.30	9.31	8.27	1.55	2.59	0.00	0.52	0.00	0.00	4.65
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	62.43	7.97	5.31	2.66	7.31	0.66	1.33	0.00	1.33	1.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	46.69	5.90	5.13	2.82	4.10	0.00	1.03	0.00	0.26	2.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	49.08	4.09	6.14	1.02	5.62	0.77	0.51	0.00	1.02	1.53
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	59.06	6.06	9.84	1.51	0.76	0.00	0.00	0.00	3.03	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	47.05	4.70	5.38	1.68	6.39	0.00	0.34	0.00	1.68	2.69
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	24.63	2.90	0.97	4.83	1.45	1.69	1.45	0.00	0.97	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	27.63	2.23	0.45	2.67	0.89	0.00	1.78	0.00	0.00	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	26.34	6.34	0.98	2.93	1.95	1.46	0.49	0.00	0.49	0.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	34.23	3.67	6.11	4.28	4.58	0.00	0.00	0.00	2.14	1.53
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	120.37	9.76	6.51	3.25	42.29	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	52.29	4.30	7.61	4.30	7.94	0.99	0.66	0.00	0.99	0.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	50.35	5.47	9.85	1.64	8.21	0.55	0.55	0.00	1.09	4.38
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	55.73	6.15	8.32	1.09	7.24	0.36	0.72	0.00	1.45	3.26
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	58.01	4.98	6.41	2.85	8.90	0.36	0.00	0.00	1.78	2.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	64.44	7.16	7.16	0.00	10.74	0.00	0.00	0.00	1.19	2.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	63.11	4.60	7.85	2.98	6.77	0.81	0.54	0.00	2.30	2.57
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	58.73	2.96	5.39	1.62	5.66	0.81	0.00	0.00	1.89	2.16
immature langerhans cells, donor1	11904-125F5	8.23	4.12	1.21	0.00	0.24	0.48	0.00	0.00	0.00	0.00
immature langerhans cells, donor2	11905-125F6	2.38	10.30	1.58	0.79	0.79	6.34	2.38	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	23.94	17.03	15.80	0.66	1.80	0.09	0.57	3.79	0.19	0.57
keratoacanthoma cell line:HKA-1	10791-110H8	1.30	14.96	2.60	3.58	0.33	2.60	1.95	0.00	0.00	0.00
kidney, adult, pool1	10017-101C8	17.22	12.92	8.61	2.10	0.80	1.50	0.60	0.10	0.10	0.50
kidney, fetal, pool1	10045-101F9	48.88	20.09	9.48	5.59	3.32	1.41	1.34	0.00	0.50	1.34
large cell lung carcinoma cell line:IA-LM	10509-107D5	28.12	3.83	2.84	0.71	0.85	0.14	0.43	0.99	0.14	0.99
large cell lung carcinoma cell line:NCI-H460	10839-111E2	28.89	4.42	1.66	0.14	0.69	0.00	0.00	2.76	0.55	0.97
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	2.94	24.22	4.95	2.75	0.37	2.57	2.39	0.18	0.37	0.00
left atrium, adult, donor1	10079-102A7	35.42	0.54	5.99	0.54	1.09	0.00	0.00	1.09	0.00	0.54
left ventricle, adult, donor1	10078-102A6	15.68	0.00	3.54	2.02	0.00	0.00	0.00	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	46.51	0.27	0.27	0.00	1.37	0.00	0.00	0.00	0.00	1.92
leiomyoma cell line:10964C	10569-108B2	15.45	0.72	3.23	0.36	0.36	0.00	0.00	0.36	0.36	0.72
leiomyoma cell line:15242A	10570-108B3	14.67	0.00	1.63	0.54	0.00	0.54	0.00	0.54	1.09	0.54
leiomyoma cell line:15425	10571-108B4	20.64	0.73	0.73	0.49	0.73	0.00	0.00	0.00	0.24	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	19.05	0.00	6.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	14.64	3.14	4.18	1.05	2.09	0.00	0.00	2.09	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	28.45	0.59	0.24	0.00	0.47	0.00	0.00	0.00	0.12	0.00
liposarcoma cell line:KMLS-1	10782-110G8	42.02	0.47	2.19	0.00	1.56	0.00	0.00	0.31	0.16	0.78
liposarcoma cell line:SW 872	10726-110A6	22.78	0.49	1.95	0.12	1.58	0.00	0.00	0.12	0.24	0.73
liver, adult, pool1	10018-101C9	7.45	2.27	1.94	0.00	0.49	0.32	0.00	0.00	0.16	0.16
liver, fetal, pool1	10086-102B5	15.05	0.00	0.94	0.94	0.94	0.00	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	24.94	2.33	7.00	0.44	1.46	0.29	0.15	0.58	1.60	0.29
locus coeruleus, adult, donor10252	10165-103B3	39.68	5.35	6.27	0.18	1.85	0.37	0.37	0.18	0.55	0.37
locus coeruleus, adult, donor10258	10375-105G6	29.34	3.39	7.90	0.28	2.54	0.28	0.56	0.00	0.00	0.56
locus coeruleus, newborn, donor10223	10362-105F2	73.61	6.31	2.10	0.84	3.79	1.26	0.00	0.42	1.26	0.00
lung adenocarcinoma cell line:A549	10499-107C4	3.32	28.09	1.25	0.55	0.00	1.11	1.11	0.00	0.14	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	5.52	20.68	2.07	3.45	0.00	2.07	2.07	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	9.89	32.69	5.40	2.11	0.13	0.13	0.26	0.00	0.00	0.00
lung, adult, pool1	10019-101D1	22.68	15.47	4.84	2.60	1.42	1.65	0.83	0.35	0.12	0.95
lung, fetal, donor1	10068-101I5	64.50	25.40	6.85	5.99	4.00	2.85	0.57	0.00	1.14	0.86
lung, right lower lobe, adult, donor1	10075-102A3	40.32	8.71	7.33	2.29	2.75	1.83	0.00	0.00	0.46	0.92
lymph node, adult, donor1	10077-102A5	17.04	0.95	4.73	1.89	0.95	0.47	0.47	0.00	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	11.62	1.10	0.44	0.66	0.00	0.00	0.00	0.00	0.00	0.44
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	15.24	3.92	1.06	0.75	0.15	0.30	0.75	0.00	0.15	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	11.89	81.55	2.55	2.55	0.00	13.59	5.10	0.85	0.85	0.00
mature adipocyte, donor1	12231-129F8	19.54	1.78	4.00	0.89	0.89	0.00	0.00	0.89	0.00	0.00
mature adipocyte, donor2	12232-129F9	21.17	5.19	3.94	0.83	2.08	0.42	0.42	0.21	0.42	0.00
mature adipocyte, donor3	12233-129G1	17.07	2.61	1.66	0.71	1.66	0.00	0.47	0.47	0.24	0.24
mature adipocyte, donor4	12234-129G2	19.21	3.69	3.16	0.79	1.58	0.53	0.00	0.00	0.00	0.53
maxillary sinus tumor cell line:HSQ-89	10414-106B9	86.01	42.17	3.10	2.38	2.38	18.11	7.15	0.71	0.48	3.10
medial frontal gyrus - adult, donor10196	10170-103B8	22.56	6.77	7.90	1.13	2.26	0.00	0.00	0.00	2.26	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	38.80	22.25	13.98	0.18	2.57	0.74	0.00	3.86	0.37	0.55
medial frontal gyrus, adult, donor10258	10368-105F8	22.24	11.44	10.17	0.64	1.59	0.32	0.32	1.91	0.00	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	51.61	20.04	6.40	0.00	2.56	1.28	0.43	1.28	0.85	1.28
medial temporal gyrus - adult, donor10196	10183-103D3	24.81	9.79	11.48	0.84	2.36	0.00	0.51	1.35	1.35	0.34
medial temporal gyrus, adult, donor10252	10156-103A3	40.75	16.55	11.67	0.85	2.76	1.27	0.21	1.27	0.85	0.42
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	34.67	25.04	5.78	0.00	0.00	0.00	0.00	7.71	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	14.35	0.00	28.71	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	26.92	16.15	8.26	0.00	2.15	3.23	0.72	0.36	0.00	0.00
medulla oblongata - adult, donor10196	10174-103C3	49.32	4.54	6.49	0.65	3.89	0.00	0.65	1.30	0.65	1.30
medulla oblongata, adult, donor10252	10155-103A2	49.54	7.43	8.82	1.55	4.18	0.93	0.62	0.31	1.08	0.62
medulla oblongata, adult, pool1	10038-101F2	32.57	5.39	8.82	1.06	2.37	0.57	0.41	0.73	0.73	1.22
medulla oblongata, newborn, donor10223	10361-105F1	52.08	5.21	4.86	1.04	3.82	0.35	0.00	0.00	1.04	1.04
medulloblastoma cell line:D283 Med	10838-111E1	32.99	11.96	7.53	2.66	0.44	3.99	2.21	0.00	0.00	1.11
medulloblastoma cell line:ONS-76	10759-110E3	16.14	2.57	3.91	0.73	0.86	0.12	0.12	0.24	0.00	0.24
melanoma cell line:COLO 679	10514-107E1	26.45	5.89	4.46	1.15	2.44	0.43	0.43	2.30	0.43	1.29
melanoma cell line:G-361	10465-106H6	33.93	4.34	4.07	1.09	1.36	0.00	0.00	0.27	0.27	0.00
meningioma cell line:HKBMM	10691-109F7	13.57	0.36	1.09	1.45	0.00	0.00	0.00	0.18	0.18	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	37.89	5.29	8.81	4.41	0.88	0.88	1.76	0.00	1.76	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	76.73	18.40	16.33	3.89	3.37	3.89	3.89	0.00	2.33	1.30
mesenchymal precursor cell - adipose, donor1	11747-123G1	14.73	0.46	1.38	0.00	0.77	0.00	0.00	0.15	1.38	0.31
mesenchymal precursor cell - adipose, donor2	11748-123G2	7.45	1.82	2.36	0.73	0.91	0.18	0.36	0.00	1.27	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	7.04	1.24	1.24	0.00	0.83	0.00	0.00	0.00	0.83	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	17.56	1.40	3.51	0.14	1.12	0.28	0.28	1.26	1.55	0.42
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	13.67	0.77	3.47	0.19	0.58	0.00	0.00	0.96	2.12	0.58
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	36.09	1.39	1.39	0.00	2.08	0.69	0.69	0.00	0.69	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	3.78	6.01	1.37	0.51	0.00	0.86	0.51	0.34	0.86	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	11.04	2.42	3.68	0.00	0.58	0.46	0.00	0.12	0.69	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	19.63	0.13	2.39	0.27	0.93	0.00	0.00	0.53	0.93	0.40
mesenchymal precursor cell - cardiac, donor4	11755-123G9	11.88	0.95	2.30	0.81	0.95	0.00	0.00	0.14	1.22	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	17.50	0.14	1.42	0.43	0.71	0.00	0.00	0.43	1.00	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	23.71	3.62	3.95	0.33	1.65	0.33	0.00	0.33	0.33	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	15.91	0.55	1.94	0.69	0.42	0.00	0.00	0.28	2.08	0.42
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	23.04	0.00	2.09	0.00	0.00	0.00	0.35	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	9.60	0.61	1.02	0.20	0.61	0.00	0.00	0.41	0.41	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	14.02	2.16	1.08	1.44	0.36	0.00	0.00	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	16.14	0.93	3.10	0.52	0.41	0.10	0.00	0.00	1.24	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	13.68	0.91	2.28	0.00	0.91	0.46	0.00	0.46	0.23	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	16.36	1.26	0.84	0.00	0.84	0.00	0.00	0.00	1.26	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	16.44	0.45	1.34	0.45	0.75	0.00	0.00	0.90	2.09	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	15.67	1.66	3.41	0.53	0.70	0.00	0.00	0.61	2.54	0.53
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	26.14	0.74	3.31	0.00	1.47	0.37	0.00	2.95	0.37	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	19.74	2.86	3.15	0.29	0.57	0.00	0.00	0.86	0.00	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	23.58	0.84	1.68	0.42	2.11	0.00	0.00	0.84	0.42	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	24.20	2.74	1.83	0.00	0.46	0.46	0.00	0.46	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	23.79	2.56	2.30	1.02	1.79	0.00	0.26	0.26	0.51	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	26.96	2.36	3.14	1.57	2.09	0.00	0.00	1.57	0.52	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	27.73	1.85	1.54	0.31	0.62	0.31	0.31	0.62	0.31	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	19.06	3.77	1.18	0.71	0.94	0.24	0.00	0.24	0.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	30.80	4.06	2.37	1.02	1.02	0.00	0.34	0.00	0.00	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	19.26	4.32	3.14	0.79	0.79	0.00	0.00	1.18	1.18	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	19.46	3.24	1.39	0.46	1.39	0.46	0.00	1.39	0.93	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	27.11	0.87	2.31	0.58	3.46	0.29	0.00	2.02	0.87	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	17.62	3.79	2.45	0.67	2.23	0.00	0.22	0.45	0.22	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	26.68	3.85	2.40	0.00	2.64	0.24	0.00	0.96	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	38.87	2.20	5.87	1.47	4.40	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	24.50	2.35	1.01	0.34	1.68	0.34	0.00	0.00	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	26.20	2.87	0.82	1.23	0.82	0.82	0.00	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	25.34	1.72	2.15	0.00	2.58	0.86	0.00	0.43	0.00	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	19.14	5.47	0.00	0.00	5.47	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	20.66	0.00	0.00	0.00	5.16	0.00	0.00	0.00	0.00	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	31.83	2.27	2.27	0.00	1.62	0.32	0.00	1.30	0.32	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	30.55	0.00	0.00	1.45	1.45	0.00	0.00	0.00	1.45	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	32.52	2.67	3.73	0.00	0.53	0.00	0.00	2.13	1.07	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	40.07	2.45	1.64	0.00	7.36	0.00	0.00	0.00	0.00	2.45
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	40.04	1.17	1.55	0.00	1.17	0.00	0.39	1.17	0.78	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	35.68	0.00	0.00	0.00	2.10	0.00	0.00	0.00	0.00	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	39.74	0.99	0.99	0.00	0.99	0.99	0.00	0.00	2.98	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	33.37	0.00	0.00	0.00	4.77	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	35.58	0.59	2.37	0.00	1.78	0.00	0.00	0.59	0.59	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	25.59	0.00	1.22	0.00	2.44	0.00	0.00	1.22	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	39.90	0.00	2.53	0.00	2.53	0.00	0.00	0.63	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	18.28	1.38	1.03	0.00	1.72	0.00	0.00	0.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	30.09	0.00	2.15	0.00	0.00	0.00	0.00	0.00	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	15.97	0.00	0.00	3.99	0.00	0.00	0.00	0.00	3.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	30.99	0.00	3.44	3.44	6.89	3.44	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	19.97	0.81	1.63	0.00	0.81	0.00	0.41	0.81	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	23.83	0.00	3.97	0.00	0.00	0.79	0.00	0.79	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	19.45	1.77	1.77	0.00	0.59	0.00	0.00	0.59	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	21.82	0.00	2.18	0.62	0.62	0.00	0.00	0.62	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	24.06	0.00	4.01	1.34	0.00	0.00	0.00	1.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	24.84	1.18	3.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	23.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	16.52	0.00	1.38	0.00	0.69	0.00	0.00	0.69	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	17.32	0.99	1.98	0.00	0.00	0.49	0.00	0.00	0.49	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	19.07	0.00	1.12	0.00	0.00	0.00	1.12	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	22.26	1.27	0.00	0.64	0.64	0.00	0.00	0.00	0.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	20.55	0.81	1.61	0.40	0.81	0.00	0.00	0.00	0.00	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	21.81	0.00	0.00	2.18	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	16.47	3.80	1.27	0.00	2.53	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	13.96	20.63	2.43	3.64	0.00	7.89	1.21	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	9.04	9.04	0.00	0.00	0.00	4.52	4.52	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	13.18	18.94	1.65	0.00	0.00	8.24	0.82	0.00	0.82	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	19.45	1.59	1.39	0.20	0.79	0.40	0.00	0.00	0.20	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	27.58	2.92	3.24	0.32	0.65	0.32	0.65	0.32	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	24.45	2.04	5.09	2.04	0.00	0.00	0.00	1.02	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	17.02	10.06	6.19	3.09	0.77	0.77	0.77	1.55	0.77	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	30.71	1.42	4.49	1.42	2.13	0.00	0.00	5.20	0.47	0.71
mesothelioma cell line:ACC-MESO-4	10494-107B8	54.21	12.28	8.80	1.16	5.10	2.32	1.39	1.85	0.93	1.16
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	8.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	19.21	0.51	1.95	0.31	2.06	0.00	0.00	2.36	0.00	0.21
mesothelioma cell line:Mero-25	10850-111F4	9.53	13.39	4.31	1.36	0.00	0.68	0.45	1.59	0.00	0.00
mesothelioma cell line:Mero-41	10851-111F5	20.05	3.91	3.18	0.49	0.00	0.00	0.00	0.73	0.24	0.00
mesothelioma cell line:Mero-48a	10852-111F6	21.26	1.55	5.09	1.11	0.66	0.00	0.00	0.44	0.00	0.22
mesothelioma cell line:Mero-82	10853-111F7	9.99	0.79	1.31	0.00	0.26	0.00	0.00	0.26	1.05	0.00
mesothelioma cell line:Mero-83	10854-111F8	24.85	1.19	3.06	0.34	1.36	0.00	0.00	1.19	0.34	0.17
mesothelioma cell line:Mero-84	10855-111F9	23.51	1.52	0.76	2.02	1.52	0.51	0.25	0.25	0.51	1.26
mesothelioma cell line:Mero-95	10856-111G1	34.58	7.66	8.07	2.07	1.86	0.21	0.00	0.00	0.41	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	13.25	1.49	2.15	1.16	1.16	0.17	0.33	0.33	0.33	0.00
mesothelioma cell line:NCI-H226	10846-111E9	26.97	4.34	2.35	0.36	0.54	0.18	0.18	0.18	0.18	0.36
mesothelioma cell line:NCI-H2452	10848-111F2	12.47	0.68	1.88	0.34	0.85	0.51	0.00	0.00	0.00	0.17
mesothelioma cell line:NCI-H28	10845-111E8	35.37	6.62	3.82	1.27	1.27	0.00	0.00	0.00	0.51	0.00
mesothelioma cell line:No36	10857-111G2	18.27	0.98	1.96	0.98	0.33	0.00	0.00	2.28	0.65	0.00
mesothelioma cell line:ONE58	10858-111G3	15.72	1.08	1.63	0.54	0.27	0.54	0.54	0.54	0.00	0.27
migratory langerhans cells, donor1	11901-125F2	29.36	0.96	0.96	0.38	0.58	0.00	0.00	0.00	0.58	0.19
migratory langerhans cells, donor2	11902-125F3	17.71	0.85	1.95	0.61	0.24	0.00	0.00	0.00	0.12	0.12
migratory langerhans cells, donor3	11903-125F4	44.33	2.33	3.77	0.90	0.00	0.00	0.00	0.00	0.18	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	12.73	7.18	3.59	1.63	0.33	1.31	0.98	0.65	0.33	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	23.95	5.09	8.48	1.48	0.64	0.42	1.48	1.27	0.21	0.85
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	3.92	15.20	2.07	0.69	0.23	0.46	0.92	0.46	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	18.08	0.00	0.00	0.00	0.19	0.00	0.00	0.00	0.38	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	38.99	4.07	4.07	0.37	0.92	0.00	0.00	0.00	0.18	0.37
myeloma cell line:PCM6	10474-106I6	24.31	3.95	4.15	0.20	0.00	0.59	0.79	0.00	0.20	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	14.20	1.01	7.10	0.51	2.03	0.00	0.00	0.51	1.52	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	36.68	1.57	4.51	0.59	0.59	0.00	0.20	0.78	0.20	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	0.45	16.94	1.00	1.56	0.00	4.01	2.56	0.00	0.00	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	0.96	14.12	1.62	1.25	0.00	3.82	3.09	0.00	0.00	0.00
nasal epithelial cells, donor2	12227-129F4	2.76	11.59	0.00	1.10	0.00	1.66	0.55	0.00	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	29.22	8.05	4.14	0.23	2.53	0.69	1.15	0.00	0.46	0.46
neuroblastoma cell line:NB-1	10539-107G8	98.97	13.10	7.67	1.87	2.81	3.55	3.18	2.81	2.25	2.81
neuroblastoma cell line:NBsusSR	10607-108F4	14.55	9.07	5.06	0.63	0.84	0.63	0.21	0.00	0.00	0.00
neuroblastoma cell line:NH-12	10555-107I6	52.92	4.47	3.35	1.30	2.42	0.56	0.37	0.00	0.37	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	53.61	1.66	5.22	1.19	5.93	0.00	0.00	0.00	0.47	0.95
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	36.43	7.92	7.92	1.11	2.22	0.48	0.48	0.00	0.63	1.11
neuroectodermal tumor cell line:TASK1	10774-110F9	39.65	7.65	5.23	0.40	1.21	0.60	0.00	0.00	0.60	1.21
neuroepithelioma cell line:SK-N-MC	10728-110A8	6.99	1.91	4.45	0.64	0.00	0.00	0.00	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	28.21	4.79	5.32	1.60	1.60	0.53	0.27	0.27	0.00	0.53
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	18.94	0.00	9.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	83.71	0.17	1.35	1.52	2.54	0.00	0.00	0.00	1.01	1.01
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	8.81	0.80	1.60	0.80	0.00	0.00	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	25.97	3.85	5.45	0.32	1.92	0.32	0.32	3.53	0.00	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	18.13	0.79	4.20	0.53	2.10	0.00	0.00	2.36	1.31	0.53
nucleus accumbens, adult, pool1	10037-101F1	24.56	11.81	14.34	0.66	0.94	0.84	0.47	1.97	0.56	1.22
occipital cortex - adult, donor10196	10172-103C1	22.66	6.18	10.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	49.92	19.86	12.88	0.27	3.49	1.34	0.27	2.15	2.15	1.61
occipital cortex, newborn, donor10223	10355-105E4	17.47	13.83	13.10	0.73	0.00	2.18	1.09	1.09	0.00	0.73
occipital lobe, adult, donor1	10076-102A4	27.81	12.86	14.43	0.52	1.31	0.79	0.00	2.36	0.00	0.79
occipital lobe, fetal, donor1	10073-102A1	117.57	39.48	31.32	3.43	5.58	1.72	0.00	0.00	1.29	2.15
occipital pole, adult, pool1	10036-101E9	16.16	11.51	13.17	0.32	0.47	0.32	0.39	2.21	0.24	0.47
olfactory region, adult	10195-103E6	19.68	9.17	8.79	0.00	1.53	0.19	0.19	1.15	0.38	0.38
optic nerve, donor1	10277-104E7	30.02	6.00	14.01	2.00	4.00	0.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	17.54	20.39	5.35	5.13	0.57	6.38	2.73	0.68	0.23	0.68
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	8.38	7.14	0.82	1.65	0.14	0.27	2.61	0.00	0.00	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	3.56	7.45	1.69	1.69	0.00	1.19	0.51	0.00	0.17	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	3.12	23.45	5.08	2.77	0.35	1.16	1.16	0.12	0.00	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	29.98	2.94	4.41	1.76	1.47	0.00	0.00	1.47	2.06	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	14.95	7.47	3.74	1.87	0.00	0.00	0.00	0.93	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	38.81	4.03	1.06	0.42	2.76	1.06	1.06	7.63	0.42	1.91
ovary, adult, pool1	10020-101D2	46.12	11.62	6.99	2.62	3.14	0.70	0.17	0.17	0.26	1.14
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	19.98	3.30	3.12	0.73	0.37	0.00	0.18	0.00	0.37	0.73
pancreas, adult, donor1	10049-101G4	11.29	20.69	10.35	0.94	0.00	3.76	0.00	0.00	0.94	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	0.00	27.67	3.35	9.78	0.00	8.67	3.07	0.00	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	12.95	9.88	3.24	1.70	0.51	0.68	0.17	0.68	0.34	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	28.81	14.90	6.46	4.80	0.83	1.66	0.99	1.16	0.33	0.17
paracentral gyrus, adult, pool1	10035-101E8	16.66	11.62	15.01	0.46	1.74	0.73	0.92	2.29	0.18	0.27
parietal cortex, adult, donor10258	10373-105G4	19.08	5.14	2.20	0.73	0.00	0.00	0.00	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	25.39	3.76	5.64	0.00	0.94	0.00	0.00	0.94	0.94	0.94
parietal lobe, adult, donor10252	10157-103A4	39.62	21.09	13.68	0.57	4.56	0.57	0.86	3.14	1.14	0.86
parietal lobe, adult, pool1	10034-101E7	19.92	11.46	14.54	0.70	1.50	0.53	0.26	1.50	0.70	0.35
parietal lobe, fetal, donor1	10072-101I9	158.08	19.40	17.46	0.00	9.70	1.94	3.88	0.00	0.00	2.91
parietal lobe, newborn, donor10223	10356-105E5	36.26	20.19	10.84	0.75	1.12	3.74	0.00	1.50	0.37	1.87
parotid gland, adult	10199-103F1	15.42	31.45	3.08	1.23	0.62	3.70	0.00	0.00	0.00	0.00
penis, adult	10200-103F2	45.65	12.35	10.74	0.54	2.15	0.54	0.54	1.61	0.00	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	57.27	5.21	1.86	1.86	6.32	0.56	0.37	0.19	1.30	0.56
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	21.42	16.17	4.08	1.17	0.44	0.87	0.73	0.73	0.15	0.58
pineal gland - adult, donor10196	10179-103C8	26.45	7.74	10.32	0.65	0.00	0.00	0.65	1.94	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	20.14	10.66	17.77	2.37	1.18	0.00	0.00	0.00	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	18.19	4.39	8.15	0.63	1.25	0.63	0.00	0.00	0.00	1.25
pituitary gland - adult, donor10196	10180-103C9	30.35	13.15	6.07	1.01	3.04	0.00	1.01	0.00	0.00	2.02
pituitary gland, adult, donor10252	10162-103A9	66.19	19.80	12.51	1.04	3.13	4.69	1.04	0.00	0.00	2.08
pituitary gland, adult, donor10258	10378-105G9	23.83	11.07	5.11	0.85	0.85	2.55	0.85	0.00	0.00	0.00
placenta, adult, pool1	10021-101D3	12.69	12.15	4.09	3.55	1.29	2.37	2.26	0.54	0.32	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	34.96	0.40	0.53	0.13	0.40	0.00	0.13	0.00	0.13	0.26
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	70.04	2.49	6.85	2.49	1.87	0.00	0.16	0.00	0.31	1.71
pons, adult, pool1	10033-101E6	16.35	2.84	8.35	0.34	1.29	0.17	0.26	0.77	0.34	0.60
postcentral gyrus, adult, pool1	10032-101E5	16.65	11.86	13.34	0.70	1.66	0.44	0.26	2.79	0.70	0.44
promyelocytes/myelocytes PMC, donor1	12132-128D8	10.46	2.09	2.09	0.00	2.09	0.00	0.00	0.00	0.00	2.09
promyelocytes/myelocytes PMC, donor2	12136-128E3	38.56	0.00	0.00	0.00	5.51	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	11.74
prostate cancer cell line:DU145	10490-107B4	8.30	7.57	2.62	1.31	0.29	0.15	0.15	0.00	0.00	0.44
prostate cancer cell line:PC-3	10439-106E7	34.49	13.43	3.27	1.63	0.73	0.54	0.54	0.18	1.09	0.00
prostate, adult, pool1	10022-101D4	29.84	13.06	8.07	3.26	1.63	2.36	0.82	0.27	0.73	0.36
putamen, adult, donor10196	10176-103C5	19.36	12.98	16.52	0.24	1.65	0.24	0.94	0.24	0.94	0.00
putamen, adult, donor10252	10152-102I8	41.18	9.80	13.73	1.96	0.00	0.00	0.00	0.00	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	27.32	7.65	4.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	10.39	6.28	8.46	0.24	0.72	0.48	0.48	1.45	0.48	0.00
putamen, newborn, donor10223	10365-105F5	92.21	11.24	2.25	0.00	3.00	4.50	0.75	0.75	0.75	0.00
rectal cancer cell line:TT1TKB	10469-106I1	0.58	18.33	2.33	2.04	0.00	1.75	2.62	0.00	0.00	0.00
rectum, fetal, donor1	10067-101I4	112.67	16.69	16.69	2.78	4.17	2.78	0.00	0.00	0.00	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	7.00	5.94	5.09	0.85	0.42	0.00	0.00	0.42	0.00	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	0.00	7.87	0.00	0.00	0.00	0.00	0.41	0.00	0.00	0.00
retina, adult, pool1	10030-101E3	55.27	13.12	17.49	2.58	2.88	1.89	1.39	0.50	1.09	1.49
retinoblastoma cell line:Y79	10475-106I7	23.12	9.61	4.16	1.04	2.86	1.04	1.56	0.00	0.78	0.52
rhabdomyosarcoma cell line:KYM-1	10787-110H4	34.43	5.66	5.78	1.84	1.35	0.25	0.12	0.00	0.74	1.48
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	26.71	3.37	3.66	0.00	1.12	0.28	0.28	0.00	0.00	0.56
sacrococcigeal teratoma cell line:HTST	10695-109G2	19.70	2.27	5.30	0.76	0.00	0.00	0.00	0.00	0.76	0.00
salivary acinar cells, donor1	11771-123I7	8.58	5.34	4.05	1.94	0.32	2.91	0.49	0.00	0.00	0.00
salivary acinar cells, donor2	11772-123I8	11.70	11.57	6.88	2.89	0.41	3.72	1.51	0.00	0.00	0.00
salivary acinar cells, donor3	11773-123I9	7.28	17.88	9.93	4.63	0.00	9.27	2.65	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	22.31	45.18	3.43	1.72	0.00	3.43	0.57	0.00	0.00	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	23.69	4.22	5.82	0.34	1.18	0.25	0.17	1.18	0.17	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	23.39	5.41	6.70	0.59	0.94	0.35	0.24	0.82	0.35	0.12
seminal vesicle, adult	10201-103F3	22.22	22.75	15.87	2.12	2.12	1.06	1.06	0.00	1.06	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	12.88	26.24	10.45	5.34	0.49	4.37	3.16	0.24	0.24	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	27.68	7.55	3.77	1.76	2.01	1.01	0.25	2.77	0.75	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	36.13	3.01	5.02	3.01	1.00	0.00	0.00	1.00	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	8.87	19.48	10.61	1.88	0.27	1.34	1.07	0.81	0.40	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	12.27	52.83	5.19	2.10	0.44	4.97	3.21	0.99	0.44	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	32.90	20.13	3.35	2.19	0.52	1.94	1.03	0.00	0.13	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	15.61	2.13	1.42	0.00	0.00	0.00	0.00	0.00	1.42	0.00
skeletal muscle, adult, pool1	10023-101D5	27.11	4.92	1.44	0.96	0.60	0.24	0.00	0.36	0.72	0.24
skeletal muscle, fetal, donor1	10066-101I3	78.39	5.03	4.02	0.00	0.00	0.00	1.01	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	33.93	0.00	6.79	0.00	6.79	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	86.48	15.15	7.57	5.05	3.16	1.26	1.26	0.00	0.00	1.89
small cell cervical cancer cell line:HCSC-1	10800-110I8	27.35	6.67	5.34	2.33	1.33	1.33	1.33	0.00	0.33	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	106.22	16.08	8.83	1.58	7.56	4.41	1.58	0.32	1.26	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	49.92	15.03	5.20	2.31	0.96	0.39	0.58	0.00	0.77	1.35
small cell lung carcinoma cell line:LK-2	10541-107H1	64.78	20.44	4.12	3.30	4.78	7.91	4.62	0.00	0.33	4.62
small cell lung carcinoma cell line:NCI-H82	10842-111E5	37.80	13.83	5.15	4.50	0.80	1.29	2.09	0.00	0.00	2.09
small cell lung carcinoma cell line:WA-hT	10562-108A4	19.18	37.70	9.81	1.53	1.31	2.83	1.53	0.00	0.44	0.22
small intestine, adult, pool1	10024-101D6	13.62	31.17	7.76	3.46	0.84	2.99	2.99	0.00	0.24	0.24
small intestine, fetal, donor1	10064-101I1	34.89	11.55	8.11	2.21	2.46	1.23	0.98	0.00	0.49	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	8.72	13.85	2.05	1.03	0.00	1.54	1.54	0.00	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	39.54	4.39	8.79	1.03	0.78	0.52	0.26	0.00	0.00	0.26
somatostatinoma cell line:QGP-1	10781-110G7	4.56	34.04	2.41	0.80	0.27	0.80	0.80	0.00	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	60.79	6.19	5.05	0.69	4.82	0.00	0.00	0.23	1.38	1.38
spinal cord, adult, donor10252	10159-103A6	83.98	7.49	3.55	0.79	5.13	1.58	0.39	0.00	0.79	1.58
spinal cord, adult, donor10258	10369-105F9	68.49	3.46	4.15	0.00	1.38	0.69	0.00	0.69	0.00	0.69
spinal cord, fetal, donor1	10056-101H2	118.92	10.98	12.81	1.83	7.32	1.22	0.00	0.00	1.83	3.66
spinal cord, newborn, donor10223	10359-105E8	85.87	3.21	5.97	0.92	7.35	0.00	0.46	0.00	0.46	1.84
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	17.33	5.97	5.68	1.49	0.90	0.30	0.00	0.75	0.00	0.45
spleen, adult, pool1	10025-101D7	28.63	4.96	3.96	2.64	0.55	0.00	0.66	0.00	0.66	0.22
spleen, fetal, pool1	10044-101F8	57.21	9.61	4.13	2.78	2.46	0.87	0.48	0.00	1.03	0.16
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	34.16	0.10	0.10	0.00	0.31	0.00	0.00	0.00	0.41	0.21
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	4.18	14.62	3.61	2.85	0.19	0.57	1.90	0.00	0.00	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	8.39	33.90	4.19	3.84	0.35	4.19	3.49	0.00	0.00	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	13.68	10.56	5.08	1.95	0.39	0.39	1.95	0.00	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	14.75	14.75	5.52	1.24	0.11	1.35	2.03	0.00	0.56	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	2.54	13.98	3.39	2.97	0.00	5.08	1.69	0.00	0.42	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	26.65	12.27	13.96	6.35	1.27	1.69	0.00	0.42	0.85	0.42
stomach, fetal, donor1	10062-101H8	38.45	24.56	9.61	5.34	1.07	3.20	0.00	1.07	1.07	1.07
submaxillary gland, adult	10202-103F4	24.50	38.17	5.70	1.71	0.57	1.71	1.14	0.00	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	108.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	48.19	6.02	4.15	0.21	3.95	1.04	0.21	1.25	0.62	0.62
substantia nigra, adult, donor10258	10371-105G2	38.28	3.62	5.69	0.00	0.00	0.00	0.00	0.00	0.00	0.52
substantia nigra, newborn, donor10223	10358-105E7	93.27	7.77	5.65	0.71	1.41	0.00	0.00	2.12	2.12	2.83
synovial sarcoma cell line:HS-SY-II	10441-106E9	30.03	9.86	17.19	4.59	2.52	1.38	0.69	0.00	0.92	0.23
temporal lobe, adult, pool1	10031-101E4	20.26	11.53	10.34	0.85	1.95	0.42	0.59	2.46	0.42	0.68
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	133.91	25.64	17.09	3.56	7.12	3.56	0.00	0.71	1.42	5.70
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	98.46	26.37	13.19	3.08	2.64	1.76	0.00	0.88	1.32	2.64
tenocyte, donor1	11763-123H8	20.25	1.40	1.75	0.35	1.40	0.35	0.00	0.00	0.00	0.70
tenocyte, donor2	11765-123I1	35.48	1.14	2.67	1.14	1.14	0.38	0.00	1.53	0.00	0.38
tenocyte, donor3	11768-123I4	9.64	0.74	2.22	0.37	0.00	0.00	0.00	0.00	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	81.24	2.89	2.21	1.19	2.89	0.68	0.68	0.00	1.02	1.53
teratocarcinoma cell line:NCR-G1	10798-110I6	41.62	0.15	0.00	0.31	0.92	0.00	0.00	0.00	0.15	2.00
teratocarcinoma cell line:PA-1	10807-111A6	19.84	0.31	1.08	1.24	0.77	0.00	0.31	0.00	0.31	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	19.42	13.20	2.41	4.82	0.13	4.44	2.16	0.00	0.25	0.63
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	4.92	6.81	1.13	1.89	0.00	3.40	3.03	0.00	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	6.98	7.20	0.55	2.07	0.11	1.64	1.96	0.00	0.44	0.22
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	6.84	7.17	0.65	3.91	0.00	1.63	1.63	0.00	0.00	0.00
testis, adult, pool1	10026-101D8	51.75	5.80	10.74	1.83	2.04	0.75	0.54	0.11	1.07	1.61
testis, adult, pool2	10096-102C6	77.14	5.41	21.65	0.90	2.26	0.45	0.00	0.00	1.35	0.45
thalamus - adult, donor10196	10168-103B6	50.78	2.21	5.52	0.00	1.10	0.00	0.00	1.10	1.10	0.00
thalamus, adult, donor10252	10154-103A1	53.45	6.25	6.10	0.31	4.06	0.47	0.31	1.56	1.25	1.41
thalamus, adult, donor10258, tech_rep1	10370-105G1	83.14	1.54	6.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	19.43	0.82	6.75	0.49	1.48	0.00	0.16	0.33	0.33	0.99
thalamus, newborn, donor10223	10366-105F6	27.04	2.88	1.15	0.00	1.73	0.58	0.00	0.00	0.00	0.00
throat, adult	10209-103G2	24.47	14.48	4.74	2.75	0.75	1.25	0.50	0.00	1.50	0.00
throat, fetal, donor1	10061-101H7	95.07	15.84	10.36	3.05	3.66	0.61	0.91	0.00	2.74	2.74
thymic carcinoma cell line:Ty-82	10803-111A2	18.68	2.38	8.35	0.79	0.79	0.20	0.20	0.00	0.00	0.20
thymus, adult, pool1	10027-101D9	72.18	3.68	1.49	0.80	2.49	0.60	0.10	0.00	0.50	1.19
thymus, fetal, pool1	10043-101F7	91.54	11.95	5.20	1.25	3.74	1.77	0.73	0.00	1.87	2.18
thyroid carcinoma cell line:KHM-5M	10776-110G2	24.60	1.46	1.33	0.66	0.93	0.13	0.13	2.79	0.27	0.27
thyroid carcinoma cell line:TCO-1	10783-110G9	17.32	5.45	4.47	0.56	0.70	0.00	0.00	0.00	0.28	0.14
thyroid, adult, pool1	10028-101E1	48.34	34.62	10.26	4.95	2.52	2.05	1.31	0.00	2.33	1.40
thyroid, fetal, donor1	10060-101H6	120.76	17.93	11.86	2.90	3.43	0.00	0.26	0.00	2.64	2.90
tongue epidermis (fungiform papillae), donor1	10288-104F9	30.80	27.72	18.48	9.24	0.00	0.00	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	28.14	14.42	2.79	2.56	0.93	2.33	0.93	0.70	0.00	0.23
tongue, fetal, donor1	10059-101H5	52.02	10.64	5.12	0.79	5.12	1.18	1.18	0.39	0.00	0.00
tonsil, adult, pool1	10047-101G2	36.36	16.13	5.21	3.81	0.60	2.20	1.30	0.00	0.20	0.30
trachea, adult, pool1	10029-101E2	28.87	17.67	5.24	3.76	2.29	2.70	1.06	0.16	0.57	0.65
trachea, fetal, donor1	10058-101H4	73.48	14.23	5.39	2.31	5.39	0.77	0.38	0.00	1.54	2.31
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	19.13	1.42	2.48	0.35	0.35	0.00	0.00	0.00	0.00	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	57.75	52.08	21.58	7.29	4.86	2.94	2.13	0.81	0.61	1.22
transitional-cell carcinoma cell line:JMSU1	10492-107B6	23.19	9.24	2.82	0.94	1.25	0.31	1.10	1.10	0.31	0.31
tridermal teratoma cell line:HGRT	10694-109G1	17.12	3.81	5.71	0.00	0.00	1.90	0.00	5.71	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	11.51	8.63	1.19	0.51	0.17	0.25	0.42	0.59	0.08	0.00
umbilical cord, fetal, donor1	10057-101H3	41.73	18.78	4.17	4.17	4.17	0.00	4.17	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	74.91	14.50	10.41	3.07	2.73	2.22	0.68	0.51	1.02	0.51
uterus, fetal, donor1	10055-101H1	97.78	10.75	8.70	5.12	5.63	0.51	0.51	0.00	2.05	2.56
vagina, adult	10204-103F6	22.62	20.68	7.11	4.52	1.29	3.23	2.58	0.65	0.00	0.00
vein, adult	10191-103E2	40.33	6.80	6.80	1.75	1.53	0.44	0.22	0.22	0.66	0.88
xeroderma pigentosum b cell line:XPL 17	10563-108A5	21.10	0.80	2.40	0.53	0.27	0.00	0.00	0.00	0.00	0.27